Hydronephrosis

N14_HYDRONEPHR

hydronephrosis: Collection of urine in the renal pelvis that results in dilatation of the renal pelvis and calyces. It is caused by obstruction of urine flow, nephrolithiasis, or vesicoureteral reflux. Signs and symptoms include flank pain, nausea, vomiting, fever, and dysuria.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 N13.0, N13.1, N13.2, N13.3
  • Hospital discharge: ICD-9 591
  • Hospital discharge: ICD-8 591
  • Cause of death: ICD-10 N13.0, N13.1, N13.2, N13.3
  • Cause of death: ICD-9 591
  • Cause of death: ICD-8 591

2 out of 7 registries used, show all original rules.

4676

4. Check minimum number of events

None

4676

5. Include endpoints

None

4676

6. Filter based on genotype QC (FinnGen only)

4676

Control definitions (FinnGen only)

Control exclude
N14_RENALTUB

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 36341 17231 18729
Only index persons 29748 14472 15276
Unadjusted period prevalence (%)
Whole population 0.51 0.49 0.52
Only index persons 0.56 0.53 0.58
Median age at first event (years)
Whole population 64.20 61.27 66.85
Only index persons 62.75 59.10 66.22

-FinnGen-

Key figures

All Female Male
Number of individuals 4676 2220 2456
Unadjusted period prevalence (%) 0.93 0.76 1.08
Median age at first event (years) 62.88 56.43 68.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4162
Matched controls
41617
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
72.9
323.0
1421
293
UKB02
NOMESCO Finland
Retrograde ureteroscopy
56.1
323.0
447
89
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
+∞
323.0
369
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
89.4
323.0
726
98
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
516.4
323.0
801
19
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
+∞
323.0
710
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
33.5
323.0
511
173
UKC02
NOMESCO Finland
Cystoscopy
8.7
323.0
1965
3894
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
833.9
323.0
380
5
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
20.2
323.0
1036
672
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
90.5
323.0
1261
199
KA3EB
NOMESCO Finland
Antegrade pyelography
398.6
323.0
367
10
KA1FN
NOMESCO Finland
Isotope renography
113.1
323.0
371
36
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
16384.0
323.0
3097
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
230.7
323.0
397
19
KA1AE
NOMESCO Finland
Kidney ultrasound examination
31.2
323.0
514
187
KH1AD
NOMESCO Finland
CT of urinary organs
14.4
317.4
560
443
J01MA02
ATC
ciprofloxacin; systemic
3.6
315.1
2235
10226
KBV10
NOMESCO Finland
Removal of stent from ureter
81.0
310.7
350
47
N17.9
ICD-10 Finland
Acute renal failure, unspecified
258.3
306.3
311
13
5910A
ICD-9 Finland
Hydronephrosis[HYDRONEPHROSIS]
+∞
282.5
268
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.0
279.6
1047
2638
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
30.7
278.7
378
135
N20.1
ICD-10 Finland
Calculus of ureter
10.4
278.5
577
632
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
929.9
269.8
262
*
N18.8
ICD-10 Finland
Other chronic renal failure
64.1
265.0
309
52
R31
ICD-10 Finland
Unspecified haematuria
5.1
255.5
920
2198
KBV00
NOMESCO Finland
Insertion of stent into ureter
115.0
248.5
269
25
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
508.8
244.1
241
5
N13.2
ICD-10 Finland
Hydronephrosis with renal and ureteral calculous obstruction
+∞
241.0
229
*
N20.0
ICD-10 Finland
Calculus of kidney
16.7
237.7
392
257
J01EA01
ATC
trimethoprim; systemic
3.4
236.4
1484
5818
R33
ICD-10 Finland
Retention of urine
5.3
214.6
724
1581
JN3AD
NOMESCO Finland
Abdominal CT examination
5.9
212.4
649
1258
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
101.9
202.4
222
23
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.0
194.5
387
383
N02AA05
ATC
oxycodone; systemic
3.7
191.2
992
3255
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
54.5
189.5
227
44
59199
ICD-8 Finland
Hydronephrosis
+∞
178.4
170
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
11.5
170.3
330
308
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
167.9
1210
4996
Z51.5
ICD-10 Finland
Palliative care
5.3
162.8
542
1144
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
75.9
160.0
182
25
U14
ICPC
Kidney symptom/complaint
23.0
157.4
231
106
B01AB10
ATC
tinzaparin; parenteral
5.1
156.5
541
1188
J01MA12
ATC
levofloxacin; systemic
3.0
153.5
1085
4379
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
153.4
1433
6880
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.7
153.0
375
527
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
151.4
803
2628
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.4
149.7
419
711
JN4AD
NOMESCO Finland
Body CT examination
4.5
149.5
582
1444
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
11.1
149.1
294
283
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
20.2
145.0
222
116
N19
ICD-10 Finland
Unspecified kidney failure
13.9
142.0
251
191
XKD00
NOMESCO Finland
Uroflowmetry
2.9
141.6
1033
4226
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.4
139.5
389
655
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.5
138.9
442
878
Q62.10
ICD-10 Finland
Congenital unilateral occlusion of the pelvic ureteral junction
183.6
136.4
142
8
H02AB02
ATC
dexamethasone; systemic
3.6
135.6
697
2207
JN4BD
NOMESCO Finland
Extensive body CT
3.5
135.4
737
2441
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
23.0
135.2
198
90
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
134.7
657
1991
A11CC03
ATC
alfacalcidol; systemic
22.7
133.8
197
91
TKC20
NOMESCO Finland
Catheterisation of bladder
4.4
133.4
532
1344
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
11.9
131.9
251
224
N18.0
ICD-10 Finland
End-stage renal disease
+∞
129.8
124
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
141.6
129.0
137
10
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
15.8
128.5
215
143
TK800
NOMESCO Finland
Hemodialysis
23.7
128.2
186
82
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
11.2
127.5
249
234
N20.9
ICD-10 Finland
Urinary calculus, unspecified
8.1
123.2
290
380
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.0
122.7
834
3219
KA3GB
NOMESCO Finland
Retrograde pyelography
113.5
121.7
132
12
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
9.8
121.2
254
273
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
121.1
418
906
N30.0
ICD-10 Finland
Acute cystitis
3.2
120.9
731
2598
KAH41
NOMESCO Finland
Percutaneous endoscopic pyeloureteroplasty with division of ureteropelvic junction
409.0
120.3
120
*
KBH20
NOMESCO Finland
Replantation of ureter
132.0
119.8
128
10
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
116.1
645
2150
130
Kela drug reimbursment
Malignant tumour
3.5
114.2
591
1863
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
113.9
1602
9147
B03XA02
ATC
darbepoetin alfa; parenteral
18.6
112.8
177
99
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
41.4
111.2
140
35
A04AA02
ATC
granisetron; systemic, transdermal
4.4
110.4
439
1096
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
15.9
108.1
180
118
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
278.0
106.4
108
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
104.7
1029
4887
A12AA04
ATC
calcium carbonate; oral
28.8
103.6
142
51
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.6
102.9
506
1523
WW500
NOMESCO Finland
Blood transfusion
5.5
101.8
320
620
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
+∞
100.4
96
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.8
99.8
240
324
V03AE01
ATC
polystyrene sulfonate; oral
31.9
99.7
133
43
R50.9
ICD-10 Finland
Fever, unspecified
2.8
98.9
715
2832
Z94.0
ICD-10 Finland
Kidney transplant status
52.7
98.3
118
23
C03CA01
ATC
furosemide; systemic
2.2
97.8
1381
7767
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
27.6
96.8
134
50
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
29.4
96.2
131
46
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
95.1
1913
12418
128
Kela drug reimbursment
Cancers of female genital organs
9.9
94.2
196
207
N17.8
ICD-10 Finland
Other acute renal failure
462.6
91.6
91
*
7143
FHL
Pyeloureteroplasty
897.2
90.1
88
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
88.7
1460
8676
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
227.2
86.7
89
*
SPAT1262
SPAT
Handing over of treatment supplies
2.4
85.2
888
4283
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
84.4
561
2087
L01BC06
ATC
capecitabine; oral
5.0
82.5
281
594
Z49.0
ICD-10 Finland
Preparatory care for dialysis
126.9
81.2
87
7
A04AA01
ATC
ondansetron; systemic, rectal
3.5
80.4
409
1254
WZC30
NOMESCO Finland
Teaching
2.6
79.8
664
2829
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
79.5
738
3337
N20.2
ICD-10 Finland
Calculus of kidney with calculus of ureter
30.5
79.5
107
36
KAH40
NOMESCO Finland
Pyeloureteroplasty with division of ureteropelvic junction
+∞
79.4
76
*
1530
FHL
Urethrocystoscopy
7.0
78.7
203
303
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
11.4
78.0
150
136
A41.9
ICD-10 Finland
Sepsis, unspecified
5.4
78.0
246
476
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.0
77.9
266
563
B01AB05
ATC
enoxaparin; parenteral
2.0
77.7
1345
8051
N30.9
ICD-10 Finland
Cystitis, unspecified
4.2
77.4
316
801
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
85.8
75.2
84
10
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.9
74.7
195
296
ZX120
NOMESCO Finland
Intravenous
2.9
74.7
501
1869
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
84.7
74.2
83
10
J01CA08
ATC
pivmecillinam; oral
1.9
74.0
1464
9174
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
11.5
73.4
140
125
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
+∞
72.1
69
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
14.3
71.8
124
89
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
41.3
70.9
89
22
KED22
NOMESCO Finland
Transurethral resection of prostate
3.2
70.9
407
1363
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
70.0
290
744
G04CA02
ATC
tamsulosin; oral
2.0
69.5
1188
7015
127
Kela drug reimbursment
Transplant complication
16.0
69.1
114
73
U70
ICPC
Pyelonephritis/pyelitis
17.4
67.0
107
63
C66
ICD-10 Finland
Malignant neoplasm of ureter
61.1
66.7
78
13
KCC10
NOMESCO Finland
Cystoprostatectomy
21.5
66.7
99
47
A41.8
ICD-10 Finland
Other specified sepsis
9.0
66.1
144
165
WX402
NOMESCO Finland
General anaesthesia
2.2
65.9
744
3674
SPAT1125
SPAT
Stoma care and guidance
8.1
65.9
153
195
J01DB01
ATC
cefalexin; oral
1.9
65.8
3238
27020
N02BE01
ATC
paracetamol; systemic, rectal
2.0
64.7
3456
29591
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
+∞
64.7
62
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
9.1
64.6
140
159
JAH00
NOMESCO Finland
Laparotomy
5.0
64.5
217
451
N02AX02
ATC
tramadol; systemic, rectal
1.8
63.9
1727
11868
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.7
63.8
230
515
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
10.5
62.7
125
122
SPAT1255
SPAT
Intravenous administration of medicine
3.2
60.5
347
1156
SPAT1167
SPAT
Insertion of urinary catheter
4.5
59.7
221
508
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
59.6
512
2196
U29
ICPC
Urinary symptom/complaint other
5.1
59.4
197
403
137
Kela drug reimbursment
Uraemia requiring dialysis
48.8
59.4
72
15
U99
ICPC
Urinary disease other
19.0
58.9
91
49
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.2
58.7
190
378
L03AA13
ATC
pegfilgrastim; parenteral
4.1
58.5
240
609
V03AE02
ATC
sevelamer; oral
295.9
57.4
58
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
57.3
244
641
116
Kela drug reimbursment
Prostate cancer
2.8
57.1
400
1521
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
56.4
818
4473
L04AA06
ATC
mycophenolic acid; systemic
10.7
56.4
111
106
163
Kela drug reimbursment
Abiraterone and enzalutamide
7.9
56.3
132
171
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
89.9
56.0
62
7
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
55.9
500
2188
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
55.0
1295
8409
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.2
54.6
125
156
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.3
53.9
571
2714
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
115.5
52.9
57
5
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.3
52.8
550
2592
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
56.2
51.7
61
11
A02BC02
ATC
pantoprazole; systemic
1.6
51.6
2525
20106
196
Kela drug reimbursment
Paricalcitol and cinacalcet
514.1
51.5
51
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
50.9
849
4875
N21.0
ICD-10 Finland
Calculus in bladder
8.2
49.9
114
142
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.4
49.2
98
96
J01MA06
ATC
norfloxacin; oral
2.2
49.0
574
2852
L02BB03
ATC
bicalutamide; oral
3.7
48.6
226
640
KBT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of ureter
19.3
48.4
74
39
TKC22
NOMESCO Finland
Catheterisation instruction
5.2
48.3
156
310
U05
ICPC
Urination problems other
3.4
48.3
246
749
KH1RT
NOMESCO Finland
Urinary tract dilatatation with radiological guidance
168.6
47.9
50
*
U28
ICPC
Limited function/disability (U)
10.2
47.7
96
96
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
10.2
47.7
96
96
WF004
NOMESCO Finland
Palliative radiotherapy
5.3
47.4
149
287
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
126.5
46.8
50
*
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
31.4
46.7
62
20
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
46.6
660
3545
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
462.7
46.4
46
*
M05BX04
ATC
denosumab; parenteral
3.2
46.2
256
830
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.5
46.1
170
389
N13.5
ICD-10 Finland
Kinking and stricture of ureter without hydronephrosis
+∞
45.9
44
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
232.4
45.0
46
*
TJF80
NOMESCO Finland
Ostomy education
9.5
44.9
94
101
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.8
44.4
155
336
U07
ICPC
Urine symptom/complaint other
2.9
44.1
284
1019
A28
ICPC
Limited function/disability NOS
2.0
44.0
646
3514
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.0
44.0
273
956
L02BX03
ATC
abiraterone; oral
10.7
43.8
86
82
N13.4
ICD-10 Finland
Hydroureter
+∞
43.8
42
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.3
42.8
233
745
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
+∞
42.8
41
*
UJF32
NOMESCO Finland
Coloscopy
1.7
42.2
1028
6639
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
41.9
370
1597
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.7
41.8
194
548
KH1LA
NOMESCO Finland
Kinetic X-ray examination of urinary tract with pictures
22.1
41.8
61
28
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
41.6
445
2109
JAL30
NOMESCO Finland
Omentectomy
7.6
41.4
99
133
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.4
41.4
111
176
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
41.0
219
691
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
41.0
438
2076
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.4
40.8
390
1749
R11
ICD-10 Finland
Nausea and vomiting
2.5
40.8
346
1461
B05DA
ATC
Isotonic solutions
39.7
40.6
51
13
JFB00
NOMESCO Finland
Partial resection of small intestine
5.8
40.5
118
208
L02AE02
ATC
leuprorelin; implant, parenteral
2.7
40.2
290
1116
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
39.6
228
759
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.9
39.2
112
193
204
Kela drug reimbursment
Leukemia lymphatica
4.0
39.2
165
429
JFF10
NOMESCO Finland
Loop enterostomy
14.6
39.0
66
46
KBD00
NOMESCO Finland
Partial excision of ureter
106.0
38.8
42
*
Z49.2
ICD-10 Finland
Other dialysis
51.6
38.6
46
9
A06AH03
ATC
naloxegol; oral
7.4
38.3
93
128
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.8
38.2
267
1009
L02BB04
ATC
enzalutamide; oral
6.9
38.1
97
143
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.1
38.1
153
381
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
38.0
572
3128
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.5
38.0
138
312
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
19.0
37.9
58
31
N28.8
ICD-10 Finland
Other specified disorders of kidney and ureter
26.3
37.6
52
20
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
7.9
37.5
87
112
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.5
37.2
180
526
C08CA01
ATC
amlodipine; oral
1.6
36.8
1378
9924
Q62.0
ICD-10 Finland
Congenital hydronephrosis
101.0
36.8
40
*
TK810
NOMESCO Finland
Hemofiltration
38.8
36.5
46
12
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
36.1
352
1595
352
Kela drug reimbursment
Abiraterone and enzalutamide
7.3
35.9
88
123
N99.5
ICD-10 Finland
Malfunction of external stoma of urinary tract
127.8
35.7
38
*
SPAT1254
SPAT
Administration of medicine
1.9
35.2
588
3333
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
7.1
35.2
88
127
A06AD11
ATC
lactulose; oral
1.9
35.0
606
3477
KBH62
NOMESCO Finland
Transluminal endoscopic dilatation of ureter
181.5
34.8
36
*
P01AB01
ATC
metronidazole; oral, rectal
1.6
34.6
1409
10322
A04AD12
ATC
aprepitant; systemic
4.7
34.5
120
260
SPAT1263
SPAT
Sampling
1.5
34.5
1607
12144
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
4.7
34.1
120
263
KAC20
NOMESCO Finland
Nephroureterectomy
42.4
34.0
42
10
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
339.8
34.0
34
*
E87.5
ICD-10 Finland
Hyperkalaemia
7.0
33.9
85
123
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.8
33.9
117
251
V03AE03
ATC
lanthanum carbonate; oral
176.4
33.8
35
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
32.9
348
1638
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
4.2
32.8
128
311
U13
ICPC
Bladder symptom/complaint other
3.6
32.8
156
451
Z43.6
ICD-10 Finland
Attention to other artificial openings of urinary tract
171.3
32.7
34
*
5920A
ICD-9 Finland
Calculus of kidney and ureter, Calculus of kidney
18.7
32.6
50
27
B03XA01
ATC
erythropoietin; parenteral
10.8
32.6
63
59
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.0
32.4
106
215
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
32.3
582
3379
N13.6
ICD-10 Finland
Pyonephrosis
+∞
32.3
31
*
ZX136
NOMESCO Finland
Intravesicalis
8.0
32.2
74
94
WX320
NOMESCO Finland
Spinalanesthesy
1.7
32.2
879
5795
KH1EE
NOMESCO Finland
Urologic ultrasound examination
19.4
31.7
48
25
JAH01
NOMESCO Finland
Laparoscopy
2.9
31.7
200
709
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.2
31.5
341
1619
KH1CB
NOMESCO Finland
Urography with X-ray
27.1
31.5
43
16
U06
ICPC
Haematuria
3.7
31.5
142
393
A04AA55
ATC
palonosetron, combinations; systemic
3.6
31.4
147
419
H05BX01
ATC
cinacalcet; oral
17.7
31.4
49
28
K56.7
ICD-10 Finland
Ileus, unspecified
4.9
31.3
104
215
B05DB
ATC
Hypertonic solutions
39.4
31.2
39
10
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
30.6
258
1083
L04AD01
ATC
ciclosporin; systemic
5.6
30.5
91
166
L03AA02
ATC
filgrastim; parenteral
3.5
30.5
148
435
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.4
30.3
73
100
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
6.7
30.3
78
118
59000
ICD-8 Finland
Infections of kidney, Pyelonephritis chronica
+∞
30.2
29
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
3.4
30.2
149
444
G04AC01
ATC
NA
3.6
29.9
141
405
N35.9
ICD-10 Finland
Urethral stricture, unspecified
5.6
29.8
88
159
N18
ICD-10 Finland
Chronic kidney disease
11.6
29.5
55
48
KH1DD
NOMESCO Finland
CT urography of urinary organs
30.3
29.4
39
13
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
7.2
29.3
72
102
KCW96
NOMESCO Finland
Other operations on bladder
8.2
29.2
66
82
N13.7
ICD-10 Finland
Vesicoureteral-reflux-associated uropathy
+∞
29.2
28
*
KAC00
NOMESCO Finland
Nephrectomy
15.8
28.9
47
30
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
28.9
1058
7485
Z43.5
ICD-10 Finland
Attention to cystostomy
11.9
28.9
53
45
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
25.2
28.7
40
16
WX892
NOMESCO Finland
Monitored bed care
2.2
28.7
305
1437
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
28.5
201
761
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
6.1
28.5
79
132
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
28.2
914
6271
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
5.7
28.1
82
146
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.7
28.1
127
353
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
7.1
27.8
69
99
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
11.4
27.8
52
46
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
33.0
27.7
36
11
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
27.6
763
5022
JEA00
NOMESCO Finland
Appendectomy
2.3
27.4
255
1126
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
3.7
27.3
124
346
C07AB07
ATC
bisoprolol; oral
1.4
27.1
1799
14401
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
+∞
27.1
26
*
KC1GB
NOMESCO Finland
Cystography with X-ray
5.5
26.9
81
150
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
26.9
192
734
M04AA01
ATC
allopurinol; systemic
1.8
26.9
503
2946
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
12.8
26.6
47
37
J01XE01
ATC
nitrofurantoin; oral
4.3
26.5
99
232
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
7.7
26.5
62
82
L03AA14
ATC
lipegfilgrastim; parenteral
4.1
26.4
104
256
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
5.6
26.3
78
142
R18
ICD-10 Finland
Ascites
4.4
26.2
97
225
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
26.1
235
1019
R4110
NOMESCO Finland
Physiotherapy
1.5
26.0
956
6745
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
10.3
25.9
51
50
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
25.8
299
1462
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.1
25.8
82
162
TKD00
NOMESCO Finland
Dilatation of urethra
6.5
25.6
67
104
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
25.5
228
986
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
4.7
25.4
87
187
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
50.3
25.2
30
6
Y77
ICPC
Malignant neoplasm prostate
2.7
25.1
175
662
U76
ICPC
Malignant neoplasm of bladder
18.2
24.8
38
21
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.0
24.7
357
1909
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
4.2
24.6
96
235
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
24.4
580
3651
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
22.0
24.3
35
16
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
9.0
24.2
51
57
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.6
24.2
110
308
WX002
NOMESCO Finland
Sedation and analgesia
1.6
24.1
734
4934
J01MA01
ATC
ofloxacin; systemic
1.9
24.1
356
1916
U08
ICPC
Urinary retention
3.9
24.1
100
259
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.5
24.0
87
198
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
+∞
24.0
23
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
9.9
23.9
48
49
N03AX16
ATC
pregabalin; oral
1.6
23.8
805
5550
K65.0
ICD-10 Finland
Acute peritonitis
5.6
23.8
70
127
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.8
23.8
157
573
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
6.2
23.7
64
104
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
41.6
23.6
29
7
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.4
23.4
116
348
SPAT1168
SPAT
Catheterisation training
8.4
23.3
51
61
R4190
NOMESCO Finland
Nutritional therapy
3.0
23.2
135
455
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.5
23.2
83
187
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
54.3
23.0
27
5
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
14.0
23.0
39
28
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
22.9
909
6496
5911A
ICD-9 Finland
Hydronephrosis[HYDROURETERONEPHROSIS]
+∞
22.9
22
*
JFF23
NOMESCO Finland
Transversostomy
5.3
22.9
70
133
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.9
22.8
96
252
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
22.8
605
3921
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.7
22.7
78
169
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
231.1
22.6
23
*
U71
ICPC
Cystitis/urinary infection other
2.3
22.5
217
975
TK820
NOMESCO Finland
Peritoneal dialysis
32.4
22.4
29
9
LCD00
NOMESCO Finland
Hysterectomy
2.6
22.3
171
680
N30
ICD-10 Finland
Cystitis
2.1
22.3
252
1217
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
6.6
22.2
57
87
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.9
22.0
62
107
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
22.0
241
1151
Z93.3
ICD-10 Finland
Colostomy status
6.7
21.9
56
85
59330
ICD-8 Finland
Other diseases of kidney and ureter, Obstruction of ureter, not elsewhere classified
+∞
21.9
21
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
+∞
21.9
21
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
21.9
21
*
KBH21
NOMESCO Finland
Percutaneous endoscopic replantation of ureter
+∞
21.9
21
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
21.8
1740
14204
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.0
21.7
49
62
ZX112
NOMESCO Finland
Subcutaneous
3.3
21.6
109
332
L02BX02
ATC
degarelix; parenteral
4.4
21.4
78
179
ZXA00
NOMESCO Finland
Right side
1.5
21.4
993
7320
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
21.1
548
3523
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
21.1
170
697
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.2
21.0
80
192
KBH96
NOMESCO Finland
Other repair or connection of ureter
+∞
20.8
20
*
KAH62
NOMESCO Finland
Endopyelotomy
77.2
20.7
23
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.4
20.6
62
116
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.1
20.5
56
93
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
20.2
242
1198
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
20.2
1516
12197
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
11.7
20.2
37
32
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
20.2
2148
18308
N30.2
ICD-10 Finland
Other chronic cystitis
6.2
20.1
54
88
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.7
20.0
87
236
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.0
19.9
55
93
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
5.3
19.9
61
117
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
19.9
120
415
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
12.6
19.8
35
28
KBH50
NOMESCO Finland
Ureterolysis
+∞
19.8
19
*
KAH30
NOMESCO Finland
Pyeloureteroplasty without division of ureteropelvic junction
+∞
19.8
19
*
Q62.18
ICD-10 Finland
Other specified atresia and stenosis of ureter
+∞
19.8
19
*
5937A
ICD-9 Finland
Other disorders of kidney and ureter, Vesicoureteric reflux
+∞
19.8
19
*
L28
ICPC
Limited function/disability (L)
1.6
19.7
550
3598
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
73.8
19.7
22
*
E86
ICD-10 Finland
Volume depletion
3.5
19.6
92
266
7532A
ICD-9 Finland
Congenital anomalies of urinary system, Obstructive defects of renal pelvis and ureter
200.8
19.6
20
*
KAE01
NOMESCO Finland
Nephroscopic nephrolithotomy
40.3
19.5
24
6
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
4.1
19.4
76
188
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.3
19.4
175
764
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
19.3
758
5377
5921A
ICD-9 Finland
Calculus of kidney and ureter, Calculus of ureter
4.2
19.2
73
176
R53
ICD-10 Finland
Malaise and fatigue
1.5
19.1
685
4761
205
Kela drug reimbursment
Chronic hypertension
1.4
19.1
1050
7974
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
14.0
19.0
32
23
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
5.6
19.0
55
99
SPAT1301
SPAT
No procedures
1.4
18.9
1145
8848
KCC00
NOMESCO Finland
Cystectomy
55.2
18.9
22
*
KDE20
NOMESCO Finland
Removal of foreign body from urethra
5.6
18.8
55
100
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
9.1
18.8
39
43
N15.1
ICD-10 Finland
Renal and perinephric abscess
+∞
18.8
18
*
XJH00
NOMESCO Finland
Transanal ultrasonography
1.9
18.7
286
1559
N11.1
ICD-10 Finland
Chronic obstructive pyelonephritis
190.8
18.5
19
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
18.5
269
1439
A79
ICPC
Malignancy NOS
3.8
18.4
77
203
N99.1
ICD-10 Finland
Postprocedural urethral stricture
6.4
18.3
48
76
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
7.2
18.2
44
62
ZXA05
NOMESCO Finland
Left side
1.4
18.2
921
6872
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
17.6
18.2
28
16
321
Kela drug reimbursment
Paricalcitol and cinacalcet
11.0
18.2
34
31
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.9
18.2
45
66
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.7
18.0
80
222
L02AE03
ATC
goserelin; implant
3.8
18.0
76
202
B37.7
ICD-10 Finland
Candidal sepsis
33.0
17.9
23
7
XX9LA
NOMESCO Finland
Complementary kinetic X-ray examination without contrast
6.5
17.9
46
71
C56
ICD-10 Finland
Malignant neoplasm of ovary
8.7
17.9
38
44
WF001
NOMESCO Finland
Preoperative radiotherapy
4.7
17.9
60
128
KCF02
NOMESCO Finland
Transluminal endoscopic removal of foreign body from bladder
22.8
17.7
25
11
R06.0
ICD-10 Finland
Dyspnoea
1.4
17.7
851
6284
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.4
17.6
155
668
C20
ICD-10 Finland
Malignant neoplasm of rectum
5.6
17.6
51
92
N26
ICD-10 Finland
Unspecified contracted kidney
36.8
17.6
22
6
75329
ICD-8 Finland
Congenital anomalies of urinary system, Hydronephrosis alia sive hydroureter alius sive NUD
95.4
17.6
19
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
17.5
263
1425
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
17.5
474
3078
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
8.0
17.5
39
49
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
6.5
17.4
45
70
7124
FHL
Nephrectomy (simple
28.9
17.4
23
8
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
9.5
17.3
35
37
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
4.8
17.3
57
119
M10.3
ICD-10 Finland
Gout due to impairment of renal function
13.9
17.2
29
21
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
17.1
324
1896
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
17.1
232
1209
C67
ICD-10 Finland
Malignant neoplasm of bladder
14.8
17.1
28
19
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
4.2
16.9
64
154
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
9.5
16.9
34
36
WX110
NOMESCO Finland
Local anesthesy
1.3
16.8
2385
20967
L01BC59
ATC
trifluridine, combinations; systemic
14.1
16.8
28
20
SPAT1211
SPAT
Application of soft bandage
1.8
16.7
315
1840
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
63.6
16.7
19
*
59358
ICD-8 Finland
Other diseases of kidney and ureter, Morbi ureteris alii
+∞
16.7
16
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
+∞
16.7
16
*
Z93
ICD-10 Finland
Artificial opening status
10.4
16.6
32
31
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
15.1
16.6
27
18
H02AB06
ATC
prednisolone; systemic
1.3
16.6
1639
13652
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
90.4
16.6
18
*
JFB30
NOMESCO Finland
Right hemicolectomy
3.5
16.6
76
217
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
16.6
166
761
KBJ80
NOMESCO Finland
Operation for malfunction of urinary diversion
170.6
16.5
17
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
170.6
16.5
17
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
3.1
16.5
92
304
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
10.8
16.4
31
29
N21.1
ICD-10 Finland
Calculus in urethra
10.8
16.4
31
29
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
23.1
16.4
23
10
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
10.1
16.4
32
32
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
3.3
16.2
83
258
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
16.2
506
3402
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.9
16.0
65
168
KCB00
NOMESCO Finland
Biopsy of bladder
8.6
15.9
34
40
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
15.9
302
1770
RS220
NOMESCO Finland
NA
4.6
15.9
55
122
A02BC01
ATC
omeprazole; systemic
1.4
15.8
975
7516
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
5.4
15.8
47
88
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.2
15.8
28
23
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.9
15.8
51
105
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
15.8
243
1330
WX882
NOMESCO Finland
High dependency care
2.7
15.7
106
395
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
15.6
623
4417
5933A
ICD-9 Finland
Other disorders of kidney and ureter, Stricture or kinking of ureter
+∞
15.6
15
*
B02AA02
ATC
tranexamic acid; systemic
1.6
15.6
441
2889
KBV04
NOMESCO Finland
Laparoscopic insertion of stent into ureter
160.5
15.5
16
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.4
15.4
56
130
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
6.2
15.4
41
67
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.3
15.3
76
231
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.7
15.3
108
414
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
15.3
258
1457
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
5.5
15.2
44
80
A10BH05
ATC
linagliptin; oral
2.2
15.2
155
719
TPX15
NOMESCO Finland
Removal of vascular injection port
10.4
15.2
29
28
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
10.4
15.2
29
28
J01MA14
ATC
moxifloxacin; systemic
1.7
15.2
301
1790
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.6
15.1
110
429
KAC10
NOMESCO Finland
Total nephrectomy with capsule
5.2
15.1
46
89
7179
FHL
Other measure in this category
20.1
15.1
22
11
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
7.8
15.0
34
44
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
15.0
582
4103
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
14.9
91
318
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.8
14.9
63
169
KBB00
NOMESCO Finland
Biopsy of ureter
31.8
14.8
19
6
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.0
14.8
201
1050
N25.0
ICD-10 Finland
Renal osteodystrophy
56.9
14.8
17
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
7.9
14.8
33
42
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
14.7
227
1242
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
13.2
14.7
25
19
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
13.2
14.7
25
19
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
+∞
14.6
14
*
H05BX02
ATC
paricalcitol; systemic
+∞
14.6
14
*
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
+∞
14.6
14
*
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.7
14.6
63
172
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
7.7
14.6
33
43
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.9
14.5
87
303
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
14.5
881
6761
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.6
14.5
107
423
R39.1
ICD-10 Finland
Other difficulties with micturition
2.4
14.4
117
486
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
36.1
14.4
18
5
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
3.9
14.4
58
149
R10.0
ICD-10 Finland
Acute abdomen
2.6
14.4
107
424
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
9.4
14.4
29
31
B01AB04
ATC
dalteparin; parenteral
2.0
14.4
179
904
KK1XE
NOMESCO Finland
Other ultrasound examination of retroperitoneal space and genito-urinary tract
15.4
14.4
23
15
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
12.6
14.3
25
20
WX702
NOMESCO Finland
Supraglottic ventilation device
2.1
14.2
171
850
E87.2
ICD-10 Finland
Acidosis
8.2
14.2
31
38
1XC07
NOMESCO Finland
NA
10.4
14.2
27
26
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
9.7
14.2
28
29
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.3
14.0
71
220
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
14.0
139
637
WW200
NOMESCO Finland
Immunization
2.7
14.0
95
355
WX610
NOMESCO Finland
Patient controlled analgesia
6.6
14.0
35
53
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.3
14.0
130
576
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
13.9
202
1083
R60.0
ICD-10 Finland
Localized oedema
1.6
13.8
353
2252
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.0
13.8
168
842
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
23.8
13.8
19
8
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.5
13.8
48
108
U04
ICPC
Incontinence urine
2.1
13.7
161
794
KDV10
NOMESCO Finland
Internal urethrotomy
3.4
13.7
65
192
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
8.6
13.7
29
34
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.4
13.7
49
113
L04AX01
ATC
azathioprine; systemic
2.2
13.6
141
659
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
5.2
13.6
41
79
176
Kela drug reimbursment
Regorafenib
12.1
13.6
24
20
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
13.5
13
*
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
+∞
13.5
13
*
A07AA09
ATC
vancomycin; oral
3.7
13.5
58
158
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
4.6
13.5
46
101
N28.1
ICD-10 Finland
Cyst of kidney
3.3
13.5
67
205
KBV32
NOMESCO Finland
Cystoscopic incision of ureteric orifice
34.1
13.5
17
5
O26.84
ICD-10 Finland
Renal disease pregnancy-related
34.1
13.5
17
5
U02
ICPC
Urinary frequency/urgency
1.6
13.4
405
2692
U95
ICPC
Urinary calculus
18.3
13.3
20
11
C02AC05
ATC
moxonidine; oral
2.1
13.3
144
686
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
13.3
1186
9648
369
Kela drug reimbursment
Regorafenib
13.8
13.2
22
16
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
13.8
13.2
22
16
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.5
13.2
61
177
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
13.1
145
698
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.9
13.1
77
265
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.7
13.1
86
317
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
13.1
224
1272
Z93.5
ICD-10 Finland
Cystostomy status
12.2
13.1
23
19
WX224
NOMESCO Finland
Blockade of obturius nerve
15.1
13.1
21
14
S18
ICPC
Laceration/cut
1.3
13.1
1438
12043
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
13.0
191
1026
WX704
NOMESCO Finland
Intubation
1.8
12.9
237
1376
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
12.9
167
857
KH1ZT
NOMESCO Finland
Removal of stone or foreign body from uringary tract with radiological guidance
50.1
12.8
15
*
ZX121
NOMESCO Finland
Central venous catheter
6.9
12.8
31
45
E87.6
ICD-10 Finland
Hypokalaemia
2.4
12.8
106
447
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
12.7
208
1162
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
4.4
12.7
45
103
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
9.0
12.7
26
29
Z93.2
ICD-10 Finland
Ileostomy status
9.7
12.7
25
26
J01XX05
ATC
methenamine; oral
4.7
12.7
42
90
SPAT1088
SPAT
Blood transfusion
5.8
12.7
35
61
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
12.6
904
7101
5934A
ICD-9 Finland
Other disorders of kidney and ureter, Other ureteric obstruction
+∞
12.5
12
*
J01CA04
ATC
amoxicillin; systemic
1.3
12.5
2883
26481
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
8.7
12.5
26
30
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.4
12.4
106
452
5AB14
NOMESCO Finland
NA
20.1
12.4
18
9
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
130.3
12.4
13
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.3
12.4
118
532
JFB46
NOMESCO Finland
Resection of sigmoid colon
3.4
12.4
58
170
N05CF01
ATC
zopiclone; oral
1.3
12.4
1103
8951
SPAT1229
SPAT
Assessment of need for aid
1.7
12.4
263
1595
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
12.3
97
399
A10AE04
ATC
insulin glargine; parenteral
1.7
12.2
278
1717
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.7
12.2
81
301
G04BD08
ATC
solifenacin; oral
1.7
12.2
238
1408
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.8
12.2
80
294
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.5
12.2
35
64
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
4.2
12.2
45
108
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.1
12.2
65
211
J01FF01
ATC
clindamycin; systemic
1.3
12.1
860
6746
7151
FHL
Kidney transplantation
26.7
12.0
16
6
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
8.7
12.0
25
29
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
5.7
11.9
33
58
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
46.8
11.9
14
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
4.8
11.9
38
79
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
14.7
11.8
19
13
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
8.4
11.8
25
30
N23
ICD-10 Finland
Unspecified renal colic
8.4
11.8
25
30
XF612
NOMESCO Finland
Measurement of central venous pressure
8.4
11.8
25
30
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
5.6
11.7
33
59
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.6
11.7
33
59
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
11.7
566
4155
U77
ICPC
Malignant neopl urinary tract other
9.6
11.7
23
24
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
11.6
160
842
LEB00
NOMESCO Finland
Biopsy of vagina
3.2
11.6
59
185
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
65.1
11.6
13
*
KBH45
NOMESCO Finland
Endoureterotomy
65.1
11.6
13
*
JKA20
NOMESCO Finland
Cholecystectomy
2.3
11.6
107
477
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
11.6
431
3004
H02AB04
ATC
methylprednisolone; systemic
1.5
11.5
455
3215
D638, N180
ICD-10 Finland
NA
+∞
11.5
11
*
59099
ICD-8 Finland
Infections of kidney, Other
+∞
11.5
11
*
7187
FHL
Ureterohydroplasty due to reflux, for example
+∞
11.5
11
*
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
2.6
11.5
80
307
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
5.6
11.4
32
57
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.8
11.4
71
253
SPAT1172
SPAT
Guidance concerning hydration
2.5
11.4
90
368
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
13.6
11.4
19
14
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
120.3
11.4
12
*
N13
ICD-10 Finland
Obstructive and reflux uropathy
120.3
11.4
12
*
KBV22
NOMESCO Finland
Cystoscopic dilatation of ureteric orifice
120.3
11.4
12
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.4
1308
10964
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
4.4
11.4
40
92
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
4.4
11.4
40
92
WVA20
NOMESCO Finland
Medicine administration
2.6
11.3
79
303
UKD02
NOMESCO Finland
Urethroscopy
6.0
11.3
30
50
WF002
NOMESCO Finland
Radical radiotherapy
1.8
11.3
190
1073
N20
ICD-10 Finland
Calculus of kidney and ureter
15.0
11.3
18
12
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
15.0
11.3
18
12
G04CA01
ATC
alfuzosin; oral
1.5
11.3
433
3037
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
35.1
11.3
14
*
I50.0
ICD-10 Finland
Congestive heart failure
1.7
11.2
232
1396
Z46.6
ICD-10 Finland
Fitting and adjustment of urinary device
17.1
11.2
17
10
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
20.1
11.1
16
8
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.3
11.1
103
461
Z43.2
ICD-10 Finland
Attention to ileostomy
11.2
11.0
20
18
UJG02
NOMESCO Finland
Proctoscopy
2.5
11.0
84
340
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.0
10.9
129
641
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
2.6
10.9
75
287
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
3.3
10.9
54
167
WX872
NOMESCO Finland
Intensive care
1.9
10.9
162
879
N05BA04
ATC
oxazepam; oral
1.3
10.9
779
6109
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.9
10.8
43
111
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
6.9
10.8
26
38
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.8
10.8
69
253
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
10.7
215
1281
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.8
10.7
168
926
TKE00
NOMESCO Finland
Needle biopsy of prostate
1.8
10.7
174
973
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
5.2
10.7
32
62
S37.1
ICD-10 Finland
Injury of ureter
21.5
10.7
15
7
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
10.6
79
315
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
6.7
10.6
26
39
KAE10
NOMESCO Finland
Pyelolithotomy
60.1
10.6
12
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
8.0
10.6
23
29
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
8.0
10.6
23
29
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
3.5
10.6
47
134
JG1CG
NOMESCO Finland
Extensive MRI of rectum
4.9
10.5
33
68
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
3.9
10.4
41
105
ZXC96
NOMESCO Finland
Robot assisted procedure
2.2
10.4
101
460
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
3.6
10.4
45
125
7105
FHL
Pyelo- or nephrolithotomy
110.3
10.4
11
*
Q62.11
ICD-10 Finland
Congenital bilateral occlusion of the pelvic ureteral junction
110.3
10.4
11
*
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
110.3
10.4
11
*
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
+∞
10.4
10
*
D638, N189
ICD-10 Finland
NA
+∞
10.4
10
*
L04AA01
ATC
[U] ciclosporin; systemic
3.4
10.4
49
146
WX600
NOMESCO Finland
Single shot through catheter
2.9
10.4
62
218
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.2
10.4
108
508
59203
ICD-8 Finland
Calculus of kidney and ureter, Calculus ureteris
2.8
10.3
63
225
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
16.1
10.3
16
10
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
16.1
10.3
16
10
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
10.3
758
5957
KBV52
NOMESCO Finland
Cystoscopic injection therapy for vesicourethral reflux
32.6
10.3
13
*
KA5AT
NOMESCO Finland
Puncture of kidney cyst with ultrasound guidance
32.6
10.3
13
*
E83.50
ICD-10 Finland
Hypercalcemia
3.5
10.3
47
137
WW200
SPAT
NA
0.6
10.3
123
2136
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
18.8
10.2
15
8
X77
ICPC
Malignant neopl genital female other
7.1
10.2
24
34
L02BA03
ATC
fulvestrant; parenteral
5.7
10.2
28
49
Z43.3
ICD-10 Finland
Attention to colostomy
9.6
10.2
20
21
N32.1
ICD-10 Finland
Vesicointestinal fistula
9.6
10.2
20
21
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
10.2
97
438
JFF24
NOMESCO Finland
Laparoscopic transversostomy
23.4
10.2
14
6
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
10.2
290
1899
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.5
10.2
46
133
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.3
10.2
36
84
K59.0
ICD-10 Finland
Constipation
1.7
10.1
189
1105
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
4.7
10.1
33
71
L01XE21
ATC
[U] regorafenib; oral
11.3
10.0
18
16
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
11.3
10.0
18
16
M10.9
ICD-10 Finland
Gout, unspecified
1.7
10.0
200
1193
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
8.4
10.0
21
25
ZX100
NOMESCO Finland
Oral
2.9
10.0
60
212
SPAT1216
SPAT
Assessment of functional ability
1.4
10.0
504
3723
NF3AA
NOMESCO Finland
Femur X-ray examination
2.6
10.0
69
266
D01
ICPC
Abdominal pain/cramps general
1.5
10.0
304
2025
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.0
10.0
38
95
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
40.1
10.0
12
*
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
40.1
10.0
12
*
7534X
ICD-9 Finland
Congenital anomalies of urinary system, Other specified anomalies of ureter
40.1
10.0
12
*
3025
Kela drug reimbursment
Calcium carbonate
40.1
10.0
12
*
XKC03
NOMESCO Finland
Water cystometry
2.2
10.0
100
463
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.2
9.9
50
157
GD1UN
NOMESCO Finland
Lung circulation SPECT
5.3
9.9
29
55
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.6
9.9
72
285
192
Kela drug reimbursment
Fulvestrant
5.8
9.9
27
47
D64.8
ICD-10 Finland
Other specified anaemias
3.0
9.9
55
186
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.9
9.8
151
829
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
9.8
131
684
KCJ00
NOMESCO Finland
Cystostomy
26.1
9.8
13
5
KC1AE
NOMESCO Finland
Percutaneous ultrasound examination of urinary bladder
10.6
9.8
18
17
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
9.7
917
7461
JG1BG
NOMESCO Finland
MRI of rectum
4.2
9.7
35
83
SPAT1153
SPAT
Removal of sutures
1.3
9.7
1080
8985
KAE11
NOMESCO Finland
Nephroscopic pyelolithotomy
55.1
9.6
11
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
55.1
9.6
11
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
9.6
379
2671
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
5.8
9.6
26
45
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.3
9.6
82
353
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
4.7
9.6
31
66
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.5
9.6
75
308
KBE22
NOMESCO Finland
Transluminal endoscopic dislodgement of impacted calculus from ureter
11.4
9.5
17
15
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
10.0
9.5
18
18
R30.0
ICD-10 Finland
Dysuria
2.0
9.5
114
573
XPX08
NOMESCO Finland
Intraoperative flow measurement
3.9
9.5
37
95
Z99.2
ICD-10 Finland
Dependence on renal dialysis
100.2
9.4
10
*
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.3
9.4
46
142
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.7
9.4
61
227
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
30.1
9.4
12
*
Z90.5
ICD-10 Finland
Acquired absence of kidney
30.1
9.4
12
*
WX199
NOMESCO Finland
Other local analgesia
2.2
9.4
91
415
O23.0
ICD-10 Finland
Infections of kidney in pregnancy
17.5
9.4
14
8
D638, N188
ICD-10 Finland
NA
+∞
9.4
9
*
5900A
ICD-9 Finland
Infections of kidney, Chronic pyelonephritis
+∞
9.4
9
*
Q62.3
ICD-10 Finland
Other obstructive defects of renal pelvis and ureter
+∞
9.4
9
*
S97
ICPC
Chronic ulcer skin
1.8
9.4
166
957
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
9.4
322
2208
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
12.3
9.3
16
13
KCV02
NOMESCO Finland
Cystoscopic balloon distension of bladder
21.7
9.3
13
6
C79.1
ICD-10 Finland
Secondary malignant neoplasm of bladder and other and unspecified urinary organs
21.7
9.3
13
6
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
6.9
9.3
22
32
N17
ICD-10 Finland
Acute renal failure
10.7
9.3
17
16
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
4.3
9.3
33
78
A03
ICPC
Fever
1.4
9.2
432
3151
N30.8
ICD-10 Finland
Other cystitis
4.6
9.2
30
65
C08CA02
ATC
felodipine; oral
1.5
9.2
302
2050
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
13.7
9.2
15
11
C10AC01
ATC
colestyramine; oral
2.2
9.1
85
383
H3603, E103
ICD-10 Finland
NA
4.1
9.1
34
84
AA1AD
NOMESCO Finland
CT of head and brain
1.3
9.1
768
6152
C82.1
ICD-10 Finland
Follicular lymphoma grade II
4.6
9.1
30
66
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
9.0
86
389
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
9.0
440
3232
RD210
NOMESCO Finland
NA
2.8
9.0
55
198
KC1GD
NOMESCO Finland
CT cystography of bladder
36.7
9.0
11
*
X75
ICPC
Malignant neoplasm cervix
36.7
9.0
11
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
9.0
9.0
18
20
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
9.0
300
2041
Z51.88
ICD-10 Finland
Other specified medical care
2.5
9.0
68
275
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
9.0
273
1820
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
7.4
8.9
20
27
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
7.4
8.9
20
27
U79
ICPC
Neoplasm urinary tract unspecified
24.0
8.9
12
5
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.6
8.9
38
106
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.3
8.9
42
127
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
12.5
8.9
15
12
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
12.5
8.9
15
12
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
12.5
8.9
15
12
SPAT1269
SPAT
Other puncture and/or drainage
3.9
8.8
34
87
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
5.3
8.7
25
47
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
8.7
103
513
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.5
8.7
38
108
KED33
NOMESCO Finland
Transurethral incision of prostate
2.6
8.7
63
249
D99
ICPC
Disease digestive system other
3.3
8.7
41
124
A46
ICD-10 Finland
Erysipelas
1.4
8.7
422
3098
SPAT1078
SPAT
Removal of central venous or arterial cannula
14.0
8.7
14
10
Q62.5
ICD-10 Finland
Duplication of ureter
50.1
8.7
10
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
50.1
8.7
10
*
C09AA02
ATC
enalapril; systemic
1.3
8.7
667
5271
C08CA03
ATC
isradipine; systemic
3.0
8.6
46
152
D06
ICPC
Abdominal pain localized other
1.6
8.6
239
1557
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
5.0
8.6
26
52
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.0
8.6
47
158
1520
FHL
Ureteropyeloscopy
8.2
8.6
18
22
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
11.6
8.6
15
13
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
8.6
157
917
5990B
ICD-9 Finland
Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM ACUTA]
4.2
8.5
31
75
KCE00
NOMESCO Finland
Cystolithotomy
16.3
8.5
13
8
N80.1
ICD-10 Finland
Endometriosis of ovary
2.4
8.5
70
298
U01
ICPC
Dysuria/painful urination
1.6
8.5
199
1244
JFC00
NOMESCO Finland
Entero-enterostomy
10.0
8.5
16
16
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
3.5
8.5
37
105
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
20.0
8.5
12
6
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
20.0
8.5
12
6
H26.3
ICD-10 Finland
Drug-induced cataract
5.1
8.4
25
49
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
8.4
118
629
7538X
ICD-9 Finland
Congenital anomalies of urinary system, Other specified anomalies of bladder and urethra
90.2
8.4
9
*
75348
ICD-8 Finland
Congenital anomalies of urinary system, Maleformationes ureteris aliae
90.2
8.4
9
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
8.4
1323
11421
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.6
8.4
58
225
R32
ICD-10 Finland
Unspecified urinary incontinence
2.2
8.4
84
391
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.6
8.4
59
232
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
6.7
8.3
20
30
Q62.2
ICD-10 Finland
Congenital megaloureter
+∞
8.3
8
*
75360
ICD-8 Finland
Congenital anomalies of urinary system, Valvula urethrae cum hydronephrosi
+∞
8.3
8
*
7536A
ICD-9 Finland
Congenital anomalies of urinary system, Atresia and stenosis of urethra and bladder neck[OBSTRUCTIO URETHRAE ET COLLI VESICAE CONGENITA]
+∞
8.3
8
*
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
3.6
8.3
35
97
KH1AE
SPAT
NA
3.8
8.3
33
87
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.3
8.3
73
320
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.0
8.3
45
151
N80.5
ICD-10 Finland
Endometriosis of intestine
5.8
8.3
22
38
K83.1
ICD-10 Finland
Obstruction of bile duct
2.9
8.3
48
167
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
8.2
104
534
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.7
8.2
53
197
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
4.7
8.2
26
55
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
2.8
8.2
52
190
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.0
8.2
93
459
JFC20
NOMESCO Finland
Other enterocolostomy
14.5
8.2
13
9
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
14.5
8.2
13
9
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
8.2
277
1893
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
8.2
99
500
Z29.0
ICD-10 Finland
Isolation
6.0
8.1
21
35
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
3.9
8.1
31
79
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
33.4
8.1
10
*
Q61.0
ICD-10 Finland
Congenital single renal cyst
33.4
8.1
10
*
Q63.1
ICD-10 Finland
Lobulated, fused and horseshoe kidney
33.4
8.1
10
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
4.4
8.0
27
61
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
8.9
8.0
16
18
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.5
8.0
62
254
N30.4
ICD-10 Finland
Irradiation cystitis
10.0
8.0
15
15
Y0699
ICD-8 Finland
Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)
3.8
8.0
32
85
WX202
NOMESCO Finland
Supraclavicular plexus blockade
2.9
8.0
46
158
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
22.0
8.0
11
5
KC1JB
NOMESCO Finland
Miktiocystography with X-ray
22.0
8.0
11
5
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
3.4
8.0
37
111
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.4
8.0
62
256
R52.0
ICD-10 Finland
Acute pain
2.1
8.0
86
414
G04BD12
ATC
mirabegron; oral
1.4
7.9
322
2284
JGB36
NOMESCO Finland
Wide excision of rectum
13.0
7.9
13
10
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.2
7.8
38
118
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
8.4
7.8
16
19
H02AB07
ATC
prednisone; oral
1.4
7.8
439
3305
JN2AD
NOMESCO Finland
CT examination of lower part of abdomen
10.8
7.8
14
13
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
10.8
7.8
14
13
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
10.8
7.8
14
13
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.9
7.8
18
26
306
Kela drug reimbursment
Erythropoietin and darbepoetin
6.9
7.8
18
26
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.4
7.7
64
274
K56.0
ICD-10 Finland
Paralytic ileus
3.3
7.7
37
114
C53.81
ICD-10 Finland
Overall squamous cell carcinoma of the cervix uteri
45.0
7.7
9
*
KBV01
NOMESCO Finland
Nephroscopic insertion of stent into ureter
45.0
7.7
9
*
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.1
7.7
40
131
C09AA05
ATC
ramipril; oral
1.3
7.7
826
6812
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.6
7.7
53
204
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
2.5
7.7
57
230
B81
ICPC
Anaemia vit B12/folate deficiency
1.8
7.7
123
688
R35
ICD-10 Finland
Polyuria
1.6
7.6
199
1281
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
3.8
7.6
30
79
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
7.6
107
571
SPAT1138
SPAT
Guidance concerning bowel function
2.7
7.6
49
183
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
8.0
7.6
16
20
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.2
7.6
27
65
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
25.0
7.6
10
*
LCD30
NOMESCO Finland
Radical hysterectomy
11.8
7.6
13
11
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.7
7.6
151
905
N03AX12
ATC
gabapentin; oral
1.4
7.6
442
3346
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
7.6
850
7049
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
7.6
221
1461
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
8.8
7.5
15
17
C02CA01
ATC
prazosin; oral
2.4
7.5
60
253
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
10.0
7.5
14
14
JAK00
NOMESCO Finland
Laparotomy and drainage of peritoneal cavity
10.0
7.5
14
14
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
2.6
7.5
52
202
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
7.1
7.5
17
24
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
7.1
7.5
17
24
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
2.5
7.4
56
229
SPAT1111
SPAT
Planning of analgesia
2.9
7.4
43
150
KAE00
NOMESCO Finland
Nephrolithotomy
80.2
7.4
8
*
7188
FHL
Ureteroneocystostomy
80.2
7.4
8
*
K92.1
ICD-10 Finland
Melaena
1.6
7.4
163
1007
N32.0
ICD-10 Finland
Bladder-neck obstruction
2.9
7.4
43
151
D75
ICPC
Malignant neoplasm colon/rectum
3.6
7.3
31
87
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.9
7.3
95
495
UJK02
NOMESCO Finland
ERCP
2.0
7.3
84
418
S37.0
ICD-10 Finland
Injury of kidney
8.4
7.3
15
18
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
8.4
7.3
15
18
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
8.4
7.3
15
18
RS222
NOMESCO Finland
NA
2.8
7.3
44
159
KB1BG
NOMESCO Finland
MRI examination of urinary tract with high intensity magnet
+∞
7.3
7
*
59012
ICD-8 Finland
Infections of kidney, Pyelocystitis
+∞
7.3
7
*
A12BA02
ATC
potassium citrate; oral
+∞
7.3
7
*
KBF02
NOMESCO Finland
Transluminal endoscopic removal of foreign body from ureter
+∞
7.3
7
*
Q64.1
ICD-10 Finland
Exstrophy of urinary bladder
+∞
7.3
7
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
6.8
7.3
17
25
A03DA02
ATC
pitofenone and analgesics; systemic
2.2
7.3
67
304
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
4.5
7.2
24
54
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.2
547
4306
D20.0
ICD-10 Finland
Benign neoplasm: Retroperitoneum
15.8
7.2
11
7
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.7
7.2
136
804
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
7.2
729
5964
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.2
7.2
35
110
JFF13
NOMESCO Finland
Terminal enterostomy
7.3
7.2
16
22
A04
ICPC
Weakness/tiredness general
1.4
7.2
379
2821
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
2.1
7.2
73
343
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.6
7.2
48
185
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.6
7.1
50
196
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
6.6
7.1
17
26
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.9
7.1
95
501
JF2AB
NOMESCO Finland
Colongraphy with X-ray
5.0
7.1
21
42
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
12.0
7.1
12
10
T83.1
ICD-10 Finland
Mechanical complication of other urinary devices and implants
12.0
7.1
12
10
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
7.1
59
253
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
5.3
7.1
20
38
QBG30
NOMESCO Finland
Delayed skin closure of surgical wound in trunk
8.8
7.0
14
16
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.1
7.0
35
112
J01CF05
ATC
flucloxacillin; systemic
1.8
7.0
108
597
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
4.7
7.0
22
47
SPAT1290
SPAT
Preparation of deceased person
7.0
7.0
16
23
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
6.9
636
5139
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
4.2
6.9
24
57
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
13.8
6.9
11
8
JN3BG
NOMESCO Finland
MRI examination of abdomen with high intensity magnet
13.8
6.9
11
8
1820A
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]
13.8
6.9
11
8
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.7
6.9
131
778
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
3.1
6.9
35
114
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.2
6.9
64
292
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
4.8
6.8
21
44
59201
ICD-8 Finland
Calculus of kidney and ureter, Calculus renis
8.3
6.8
14
17
C08CA13
ATC
lercanidipine; oral
1.4
6.8
384
2894
SPAT1171
SPAT
Bladder puncture
10.9
6.8
12
11
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
10.9
6.8
12
11
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
10.9
6.8
12
11
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
5.0
6.8
20
40
SPAT1234
SPAT
Support of social functional capacity
1.6
6.8
150
926
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
9.3
6.8
13
14
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
9.3
6.8
13
14
A41.4
ICD-10 Finland
Sepsis due to anaerobes
6.1
6.8
17
28
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
40.1
6.8
8
*
75322
ICD-8 Finland
Congenital anomalies of urinary system, Hydronephrosis, obstructione non indicata
40.1
6.8
8
*
L04AA05
ATC
[U] tacrolimus; systemic
40.1
6.8
8
*
G04AA01
ATC
NA
3.2
6.8
32
99
N08.0*A41.9
ICD-10 Finland
Glomerular disease in unspecified septicemia
16.7
6.7
10
6
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
6.7
138
837
H02AB09
ATC
hydrocortisone; systemic
2.2
6.7
63
289
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.6
6.7
44
168
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
22.5
6.7
9
*
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
22.5
6.7
9
*
75340
ICD-8 Finland
Congenital anomalies of urinary system, Ureter sive pelvis renalis duplex
22.5
6.7
9
*
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
22.5
6.7
9
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
6.6
221
1507
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.8
6.6
39
139
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.7
6.6
125
740
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.5
6.6
47
187
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
3.4
6.6
29
85
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
6.6
112
642
N30.3
ICD-10 Finland
Trigonitis
12.2
6.6
11
9
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
12.2
6.6
11
9
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
4.6
6.6
21
46
K65.8
ICD-10 Finland
Other peritonitis
8.7
6.5
13
15
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
8.7
6.5
13
15
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.8
6.5
39
141
L01BB01
ATC
NA
10.0
6.5
12
12
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
6.8
6.5
15
22
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
5.0
6.5
19
38
R52.9
ICD-10 Finland
Pain, unspecified
1.5
6.5
233
1616
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.3
6.5
55
239
R34
ICD-10 Finland
Anuria and oliguria
6.2
6.5
16
26
JFF26
NOMESCO Finland
Sigmoidostomy
6.2
6.5
16
26
N36.0
ICD-10 Finland
Urethral fistula
69.9
6.4
7
*
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
69.9
6.4
7
*
N11.0
ICD-10 Finland
Nonobstructive reflux-associated chronic pyelonephritis
69.9
6.4
7
*
4AA09
NOMESCO Finland
NA
69.9
6.4
7
*
7186
FHL
Ureteroplasty, narrowing and resection (includes neoimplantation)
69.9
6.4
7
*
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
7.4
6.4
14
19
L01BC53
ATC
tegafur, combinations; systemic
7.4
6.4
14
19
JN5AN
NOMESCO Finland
Total body isotope imaging
14.3
6.4
10
7
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
14.3
6.4
10
7
R60.1
ICD-10 Finland
Generalized oedema
4.1
6.4
23
57
ZX108
NOMESCO Finland
Inhalation
3.7
6.4
25
67
JFH10
NOMESCO Finland
Total colectomy and ileostomy
6.5
6.3
15
23
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
6.5
6.3
15
23
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
6.5
6.3
15
23
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
5.2
6.3
18
35
KCH00
NOMESCO Finland
Suture of bladder
5.9
6.3
16
27
1510
Kela drug reimbursment
Niraparib
11.0
6.3
11
10
3009
Kela drug reimbursment
Niraparib
11.0
6.3
11
10
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
6.3
267
1914
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
18.0
6.3
9
5
JFB20
NOMESCO Finland
Ileocaecal resection
3.8
6.3
24
63
N17.1
ICD-10 Finland
Acute renal failure with acute cortical necrosis
+∞
6.2
6
*
59110
ICD-8 Finland
NA
+∞
6.2
6
*
5935A
ICD-9 Finland
Other disorders of kidney and ureter, Hydroureter
+∞
6.2
6
*
59001
ICD-8 Finland
Infections of kidney, Pyelonephrosis chronica
+∞
6.2
6
*
KCD98
NOMESCO Finland
Other cystoscopic partial excision of bladder or destruction of tumour of bladder
+∞
6.2
6
*
59098
ICD-8 Finland
Infections of kidney, Alia definita
+∞
6.2
6
*
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
+∞
6.2
6
*
KBH06
NOMESCO Finland
Ureteroureterostomy
+∞
6.2
6
*
KAH70
NOMESCO Finland
Freeing of adhesions of ureteropelvic junction
+∞
6.2
6
*
7119
FHL
Other measure in this category
26.7
6.2
8
*
B01AA03
ATC
warfarin; systemic
1.3
6.2
679
5600
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
2.1
6.2
64
305
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.8
6.2
19
40
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
6.2
204
1391
UJF92
NOMESCO Finland
Capsular endoscopy
2.3
6.2
54
240
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.3
6.2
54
240
JMA10
NOMESCO Finland
Transabdominal total splenectomy
4.1
6.2
22
54
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.0
6.2
33
112
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.2
6.2
57
261
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
6.3
6.1
15
24
N80.81
ICD-10 Finland
Endometriosis in sacrouteral ligament
5.7
6.1
16
28
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
5.7
6.1
16
28
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.0
6.1
71
358
SPAT1151
SPAT
Treatment of major wounds
2.6
6.1
40
152
A10BH02
ATC
vildagliptin; oral
2.2
6.1
58
266
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
3.2
6.1
29
91
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.7
6.1
106
615
N82.0
ICD-10 Finland
Vesicovaginal fistula
12.5
6.1
10
8
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
12.5
6.1
10
8
PC5YT
NOMESCO Finland
Stenting of renal artery
12.5
6.1
10
8
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
3.7
6.1
24
65
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.9
6.1
75
388
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.5
6.0
44
179
XW000
NOMESCO Finland
Bone marrow biopsy
1.7
6.0
116
692
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
10.0
6.0
11
11
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
6.7
6.0
14
21
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
6.7
6.0
14
21
A07DA03
ATC
loperamide; oral
1.7
6.0
105
607

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1290
3835
4.26
307.65
11.0
3.3
mmol/l
1.1
1.0
17.48
1237
3507
(3026008) Bacteria identified in Urine by Culture
2567
10299
4.31
307.65
6.3
2.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1093
2403
5.63
307.65
11.8
3.7
mmol/l
12.3
7.8
63.21
1058
2268
(3000850) Epithelial cells [#/volume] in Urine
1807
7445
3.33
307.65
5.4
2.2
e6/l
5.2
5.2
0.01
1677
6423
(3002582) Erythrocytes [#/volume] in Urine
2322
10812
3.28
307.65
7.3
2.8
e6/l
177.3
90.1
2.20
2030
8203
(3023368) Bacteria identified in Blood by Culture
2249
9461
3.65
307.65
7.7
3.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
760
1415
6.22
307.65
3.5
2.7
—
—
—
0
0
(3026782) Osmolality of Urine
1751
6967
3.42
307.65
5.7
2.3
mosm/kgh2o
513.9
567.3
23.54
1606
5842
(3018095) Leukocytes [#/volume] in Urine
2446
12653
2.96
285.17
8.4
3.2
e6/l
297.8
76.1
11.57
2080
8837
(3030467) Casts [#/volume] in Urine by Automated count
2077
9880
2.98
281.96
6.7
2.7
e6/l
0.4
0.4
0.68
1788
7327
(36304419) Bacteria [Presence] in Urine
1967
9587
2.82
247.77
6.6
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3589
24064
3.11
238.89
10.1
4.0
e6/l
865.1
1492.1
0.70
88
345
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3031
18701
2.76
234.56
11.1
5.7
umol/l
9.9
12.0
21.63
2935
17680
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1331
5485
2.99
226.15
5.3
3.0
mmol/l
0.8
0.8
6.45
1273
5059
(3024561) Albumin [Mass/volume] in Serum or Plasma
2662
15650
2.63
222.96
9.5
4.0
g/l
32.8
35.5
86.96
2547
14410
(3021447) Carbon dioxide [Partial pressure] in Venous blood
902
2997
3.49
219.80
7.3
2.6
kpa
5.7
5.8
3.78
878
2904
(3012544) pH of Venous blood
925
3132
3.44
218.69
7.1
2.7
ph
7.4
7.4
—
10
10
(3032080) INR in Blood by Coagulation assay
2595
15209
2.59
216.56
10.7
9.3
inr
1.2
1.3
11.70
837
4271
(3002032) Base excess in Venous blood by calculation
893
2989
3.46
214.74
7.3
2.6
mmol/l
1.2
2.2
9.92
696
2402
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2795
17105
2.58
210.69
6.8
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2124
11454
2.57
209.43
3.9
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2044
11133
2.49
193.24
3.6
2.4
u/l
56.5
58.8
1.48
1933
10198
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2872
18241
2.49
192.93
13.3
5.2
mmol/l
1.2
1.2
3.47
2397
15327
(3037467) Urinalysis macro (dipstick) panel - Urine
3558
25019
2.77
192.06
8.5
3.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1095
4502
2.87
182.24
9.1
6.1
mmol/l
105.0
104.5
2.54
1068
4389
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
453
1057
4.64
179.69
3.6
3.0
u/ml
0.3
0.4
2.81
231
609
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
680
2146
3.54
177.24
6.9
2.3
ng/l
135.8
68.9
20.67
598
1786
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
709
2301
3.45
176.88
1.9
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
515
1351
4.16
175.31
2.1
1.8
ug/l
2.8
1.9
0.75
470
1166
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1109
4844
2.69
162.17
4.0
1.8
g/l
2.1
2.4
28.26
1052
4448
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
332
652
5.40
161.01
5.5
3.1
mg/l
1.9
1.2
27.43
308
597
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1213
5588
2.58
158.72
6.3
2.6
e6/l
2.5
2.2
0.48
823
3023
(3000991) Gas panel - Venous blood
750
2681
3.14
158.64
10.6
7.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2685
17444
2.27
158.14
8.8
4.4
estimate
0.0
0.0
0.50
740
3226
(3035350) Ketones [Presence] in Urine by Test strip
2679
17404
2.26
157.60
6.6
3.3
estimate
0.0
0.0
0.00
743
3160
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1044
4492
2.70
156.74
4.2
1.9
%
21.2
23.0
3.61
927
3794
(3009261) Glucose [Presence] in Urine by Test strip
2703
17671
2.26
155.92
6.7
3.3
estimate
0.0
0.0
1.34
741
3119
(3022948) Iron [Moles/volume] in Serum or Plasma
1164
5309
2.59
155.07
4.0
1.9
umol/l
11.0
13.3
23.05
1109
4879
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2567
16504
2.23
153.36
11.1
4.8
mmol/l
1.2
1.2
0.16
2411
14789
(3013826) Glucose [Moles/volume] in Serum or Plasma
3109
21705
2.29
150.25
7.8
4.2
mmol/l
6.8
6.7
0.49
2987
20216
(3013650) Neutrophils [#/volume] in Blood by Automated count
3006
20765
2.25
148.06
16.5
8.2
e9/l
4.5
4.1
14.82
2764
17935
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
235
358
6.86
147.70
6.1
6.3
mg/l
12.7
11.3
3.37
222
337
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
924
3871
2.73
145.17
6.3
3.9
ug/l
29.5
25.7
0.16
780
3170
(1616796) Gas panel - Central venous blood
315
651
5.12
143.94
5.4
2.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
572
1858
3.37
140.99
6.1
2.4
e6/l
0.3
0.3
0.69
563
1811
(3041096) Erythrocytes [Presence] in Urine by Automated
1661
9290
2.22
136.27
6.2
3.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1165
5606
2.44
136.15
2.9
1.9
s
29.8
29.9
0.33
1142
5441
(3024354) Oxygen [Partial pressure] in Venous blood
686
2553
2.98
133.87
5.8
2.6
kpa
4.7
4.5
1.88
662
2470
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1208
5990
2.37
131.34
5.8
2.5
e6/l
3.3
1.2
0.55
812
3389
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
913
3983
2.61
131.06
4.3
4.1
u/l
250.6
241.8
0.74
883
3735
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
587
2078
3.09
124.68
6.1
2.9
kpa
4.9
5.2
13.53
554
1902
(3009343) pH of Capillary blood
579
2043
3.09
123.63
6.1
3.0
ph
7.4
7.4
5.70
103
204
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
566
1973
3.13
123.40
6.1
2.9
mmol/l
0.7
2.0
8.49
380
1461
(3022096) Basophils/100 leukocytes in Blood
2422
16199
2.03
118.89
7.3
5.6
%
0.6
0.7
11.87
2319
15010
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2116
13509
2.03
118.13
7.1
3.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2480
16784
2.02
117.09
7.6
5.9
%
8.8
8.8
0.34
2374
15594
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
454
1431
3.41
116.63
8.3
2.5
mmol/l
23.0
24.5
15.01
412
1270
(3026250) Tacrolimus [Mass/volume] in Blood
89
45
20.14
115.96
40.1
27.6
ug/l
6.9
7.8
0.77
80
37
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1131
5717
2.29
115.65
2.2
1.7
—
—
—
0
0
(4035726)
751
3157
2.64
115.11
1.5
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2519
17213
2.00
114.90
7.5
5.7
%
23.7
27.8
55.59
2405
15913
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3611
28151
2.24
114.51
14.5
6.8
u/l
88.5
78.5
17.73
3496
26305
(3006504) Eosinophils/100 leukocytes in Blood
2456
16688
1.99
113.25
7.3
5.6
%
2.6
2.9
6.46
2343
15438
(3018418) pH of Serum or Plasma
1757
10636
2.04
112.25
8.4
3.1
ph
7.4
7.4
8.84
486
1939
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1524
8766
2.10
111.82
3.7
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1947
12251
2.01
111.37
6.8
3.1
mmol/l
2.3
2.4
6.13
1762
10546
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
469
1562
3.23
109.97
8.4
3.1
u/ml
106.1
56.0
2.02
458
1500
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
542
1974
2.97
108.86
1.8
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1919
12093
2.00
108.55
6.9
5.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
481
1648
3.14
107.45
6.3
2.6
mmol/l
23.9
25.5
15.32
470
1596
(3015235) Bicarbonate [Moles/volume] in Capillary blood
308
797
4.07
105.61
4.2
2.8
mmol/l
22.8
25.6
16.65
279
679
(40768446) Kidney Pathology biopsy report
74
30
25.05
105.28
2.4
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2456
16977
1.94
104.55
7.3
5.5
%
61.0
57.2
38.09
2353
15769
(3013290) Carbon dioxide [Partial pressure] in Blood
280
693
4.23
101.89
5.6
3.6
kpa
4.8
5.1
6.89
275
681
(3012501) Base excess in Blood by calculation
280
693
4.23
101.89
5.6
3.6
mmol/l
2.2
2.7
2.20
163
472
(3027315) Oxygen [Partial pressure] in Blood
280
697
4.21
101.10
5.6
3.6
kpa
9.0
8.5
3.66
274
685
(3042936) Bacteria identified in Isolate by Culture
975
4874
2.26
100.79
2.6
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
864
4137
2.34
98.71
2.9
2.3
%
1.8
1.7
0.47
771
3612
(3006315) Basophils [#/volume] in Blood
2535
17921
1.91
98.54
7.0
5.4
e9/l
0.0
0.0
4.65
2244
15292
(3001604) Monocytes [#/volume] in Blood
2525
17829
1.90
98.50
7.0
5.4
e9/l
0.6
0.6
7.02
2230
15203
(40767503) Oxygen content in Capillary blood by calculation
268
664
4.22
97.33
3.3
2.1
%
15.8
16.4
1.12
156
308
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
216
453
4.95
96.63
6.1
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2572
18346
1.89
96.40
7.2
5.4
e9/l
1.7
1.9
5.70
2308
15956
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1540
9295
1.98
95.87
2.5
2.1
mg/l
3.2
2.9
2.54
1337
7862
(3013115) Eosinophils [#/volume] in Blood
2587
18538
1.89
95.04
7.3
5.6
e9/l
0.2
0.2
1.53
2301
16074
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
526
2026
2.80
94.73
8.1
6.8
mmol/l
23.5
25.1
18.78
520
2013
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
314
889
3.71
94.61
1.5
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
240
559
4.47
94.42
3.9
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
351
1075
3.45
93.85
5.5
2.7
g/l
0.4
0.2
1.46
251
404
(3028626) Oxygen [Partial pressure] in Capillary blood
280
737
3.98
93.62
5.3
3.1
kpa
8.4
8.1
2.29
265
675
(3010421) pH of Blood
296
833
3.73
89.91
6.0
3.4
ph
7.4
7.4
6.33
276
681
(3014111) Lactate [Moles/volume] in Serum or Plasma
671
3001
2.44
88.74
7.6
6.1
mmol/l
1.4
1.3
0.17
647
2886
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
770
3668
2.32
88.21
5.9
3.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1475
9057
1.92
85.25
7.0
3.6
%
91.6
87.7
7.81
1445
8840
(40761536) Microorganisms panel - Urine sediment
657
2995
2.39
82.93
7.8
3.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
516
2102
2.64
82.81
5.2
2.6
g/l
118.2
130.8
27.91
504
2044
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
692
3241
2.33
82.05
2.5
2.1
g/l
0.2
0.2
4.37
644
3011
(3029937) Albumin [Presence] in Urine by Test strip
1527
9585
1.88
81.78
7.4
3.6
estimate
0.0
0.0
0.51
651
3129
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
651
2981
2.38
81.24
8.1
3.0
mmol/l
1.2
1.2
2.61
602
2552
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
400
1443
2.94
80.93
1.7
1.6
g/l
1.9
1.5
9.46
352
1212
(3042733) HLA Ab [Presence] in Serum
65
37
17.80
80.10
5.4
2.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2149
15087
1.79
78.92
3.9
2.6
ug/l
199.7
125.9
13.97
2014
13790
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2032
14119
1.78
76.59
4.6
3.5
ng/l
44.8
84.1
0.65
1590
9925
(3010375) cycloSPORINE [Mass/volume] in Blood
78
72
11.00
73.01
36.1
26.3
ug/l
99.8
136.6
3.22
68
60
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
363
1317
2.90
72.50
4.5
3.2
u/ml
597.4
4129.8
0.95
325
1111
(3026493) Urate [Moles/volume] in Serum or Plasma
1442
9164
1.83
72.45
3.6
2.4
umol/l
4785.9
5667.2
0.25
1290
7791
(3023520) Reticulocytes [#/volume] in Blood
632
3066
2.23
68.11
3.0
2.3
e9/l
66.1
69.0
1.12
491
2307
(3020630) Protein [Mass/volume] in Serum or Plasma
594
2816
2.27
67.66
2.7
2.4
g/l
65.0
66.5
4.80
552
2549
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
207
560
3.82
66.39
8.4
4.1
iu/ml
662.7
3988.9
0.49
44
66
(3017181) Myelocytes/100 leukocytes in Blood
622
3032
2.21
66.13
4.1
4.0
%
1.1
1.0
0.54
271
776
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1659
11228
1.74
65.84
4.2
3.0
u/l
34.7
35.7
0.15
1573
10599
(3007853) Bacteria identified in Skin by Aerobe culture
756
3996
2.06
65.08
2.1
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
777
4150
2.05
65.01
7.9
6.5
mmol/l
0.2
1.2
7.38
589
3229
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
743
3939
2.05
63.31
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
741
3946
2.04
62.29
2.0
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
712
3738
2.07
62.22
8.2
6.8
%
95.8
95.6
0.38
680
3600
(3027801) Oxygen [Partial pressure] in Arterial blood
770
4165
2.02
61.95
7.9
6.5
kpa
13.0
12.4
2.17
727
3963
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
770
4166
2.02
61.90
7.9
6.5
kpa
4.9
5.1
4.79
730
3964
(3021440) Promyelocytes/100 leukocytes in Blood
591
2897
2.19
61.72
4.1
4.0
%
0.2
0.1
0.36
257
716
(3022313) Gas panel - Capillary blood
377
1515
2.62
61.61
7.0
3.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
169
421
4.13
60.75
4.3
2.4
u/ml
649.7
2550.6
—
10
33
(3021589) Normoblasts [#/volume] in Blood
2158
15972
1.65
59.36
19.2
8.8
e9/l
0.0
0.0
0.03
1843
12981
(3013512) EKG study
1582
10903
1.68
56.70
5.0
3.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
384
1627
2.48
56.06
4.3
2.2
%
1.2
1.2
0.05
378
1616
(3002256) Pathology report gross observation
846
4887
1.89
55.55
1.4
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
377
1595
2.48
55.19
4.3
2.2
%
0.7
0.7
2.67
372
1514
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
269
967
2.89
54.39
2.6
2.5
g/l
3.8
3.6
1.19
262
915
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
260
921
2.93
53.99
2.0
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
644
3442
2.01
52.98
8.6
7.1
g/l
111.8
122.8
35.53
621
3308
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
604
3172
2.04
52.14
3.0
2.3
u/l
37.3
38.0
0.10
546
2694
(3027570) Oxalate [Moles/time] in 24 hour Urine
34
11
31.13
51.83
1.5
1.2
umol/24h
322.9
342.2
0.09
34
11
(3002179) Metamyelocytes/100 leukocytes in Blood
545
2765
2.10
51.62
4.1
3.8
%
0.8
0.6
1.17
190
554
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
705
3923
1.94
51.52
2.9
2.7
umol/l
9.0
9.0
0.01
609
3414
(4281824)
129
299
4.41
50.97
1.2
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
251
904
2.88
50.54
2.1
3.3
ratio
1.4
3.0
1.04
22
72
(1761482) Bacteria [#/volume] in Urine by Culture
266
993
2.78
50.08
7.2
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4081
36406
1.95
50.01
34.6
12.9
mg/l
33.1
24.0
50.82
3727
28684
(3025159) Blasts/100 leukocytes in Blood
537
2744
2.08
49.82
4.2
4.0
%
0.0
0.4
1.23
217
599
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
254
934
2.82
49.20
2.2
3.3
mg/l
45.4
43.0
0.12
197
776
(3034860) Kappa light chains.free [Mass/volume] in Serum
254
936
2.81
49.00
2.2
3.3
mg/l
60.4
46.4
1.69
195
773
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
221
766
2.98
47.68
4.8
3.4
u/ml
994.4
854.2
0.06
203
709
(3004588) Protein electrophoresis panel - Serum or Plasma
463
2289
2.14
46.73
1.9
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1162
7714
1.67
46.24
5.7
4.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
1312
9012
1.63
45.54
13.5
6.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
215
756
2.93
45.20
3.5
2.0
g/l
123.5
130.8
3.57
184
517
(3003694) ABO and Rh group [Type] in Blood
1414
9965
1.60
43.84
1.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
557
3013
1.96
43.80
6.1
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1142
7653
1.65
43.38
1.9
1.7
mg/l
2.0
1.2
4.68
944
5830
(3004809) Band form neutrophils/100 leukocytes in Blood
171
541
3.24
43.11
3.2
3.6
%
1.7
1.7
0.02
143
395
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1535
11083
1.57
42.65
3.1
2.9
ng/l
2758.3
1204.8
12.20
1346
9509
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
254
1005
2.62
42.60
2.2
2.3
%
90.9
90.7
0.03
242
946
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
195
675
2.97
42.15
1.7
1.4
pmol/l
289.6
167.1
1.45
190
660
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1039
6865
1.66
41.44
5.7
2.9
mmol/l
2.5
2.4
10.34
932
6002
(40760888) Immunoglobulin light chains.free panel - Serum
194
677
2.95
41.33
2.4
3.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1063
7101
1.64
40.48
2.0
1.7
nmol/l
1218.0
1151.7
1.33
846
5276
(3024932) HLA-DR beta [Type]
50
57
8.86
40.15
1.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1931
14811
1.52
40.05
2.5
2.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
237
936
2.61
39.88
2.6
2.5
%
212.1
187.4
3.51
228
894
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
175
588
3.05
39.86
2.2
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
439
2254
2.05
39.85
9.3
8.1
%
0.7
0.7
0.15
430
2238
(3024471) HLA-A [Type]
50
58
8.70
39.61
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1549
11351
1.55
39.61
5.2
3.7
mg/mmol
23.0
5.5
16.71
1155
7022
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
57
79
7.29
38.95
2.0
2.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
159
515
3.16
38.56
2.2
1.2
u/ml
139.1
118.9
0.47
34
99
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
436
2267
2.02
38.16
9.3
8.0
%
1.2
1.4
2.77
427
2255
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
372
1852
2.10
36.60
9.4
8.5
mmol/l
23.3
24.5
7.66
351
1714
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
385
1944
2.07
36.48
10.1
8.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
323
1524
2.20
36.47
6.0
4.6
%
1.5
1.6
1.05
305
1425
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
406
2093
2.03
36.34
2.0
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
319
1501
2.21
36.26
6.1
4.6
%
0.8
0.9
2.93
303
1403
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
730
4545
1.72
35.88
2.2
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
168
589
2.92
35.50
2.1
1.2
u/ml
11.9
15.1
—
6
8
(3017143) Hepatitis C virus Ab [Presence] in Serum
587
3453
1.80
35.12
2.2
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
290
1332
2.25
34.94
8.0
3.1
mmol/l
23.7
25.0
8.80
273
1222
(3024928) Oxygen saturation in Venous blood
174
631
2.83
34.56
4.3
2.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
448
2436
1.93
34.34
5.6
4.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
140
463
3.09
32.80
3.1
2.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
152
530
2.93
32.45
1.6
1.2
u/ml
272.5
276.3
0.05
98
301
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
161
580
2.84
32.39
1.6
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
195
776
2.58
32.30
1.7
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
365
1911
1.99
31.17
6.8
3.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1832
14413
1.45
30.90
2.9
2.1
nmol/l
76.2
77.9
1.85
1669
12762
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
304
1496
2.10
30.76
2.3
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1467
11076
1.47
30.65
2.3
2.1
u/l
258.0
213.2
0.29
1399
10321
(3020876) Protein [Mass/time] in 24 hour Urine
88
225
3.97
30.61
1.9
2.0
g/24h
1.9
1.4
—
6
15
(3048929) Epstein Barr virus Ab [Presence] in Serum
208
876
2.44
30.56
1.5
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
154
560
2.81
30.45
1.8
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
166
628
2.70
30.43
2.1
2.4
umol/l
30.9
35.1
1.20
136
528
(3009508) Creatinine [Moles/volume] in Urine
1498
11402
1.46
29.83
4.3
2.9
mmol/l
6.8
7.7
15.88
1276
9446
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
282
1365
2.13
29.78
2.1
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1150
8309
1.51
29.70
6.0
3.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
4090
37696
1.68
29.48
38.4
15.1
mmol/l
139.2
139.7
35.11
4021
36645
(3036481) Cortisol [Moles/volume] in Serum or Plasma
505
2989
1.77
29.33
2.9
2.2
nmol/l
379.1
374.3
0.20
481
2715
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
80
197
4.11
29.29
1.1
1.1
u/ml
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
187
765
2.50
29.25
1.8
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
165
636
2.65
29.16
4.3
3.7
%
61.1
57.2
2.65
165
636
(3008152) Bicarbonate [Moles/volume] in Arterial blood
419
2354
1.86
28.89
8.4
6.2
mmol/l
23.5
24.7
7.37
389
2196
(3023103) Potassium [Moles/volume] in Serum or Plasma
4091
37797
1.66
28.10
38.9
15.2
mmol/l
4.0
4.0
27.72
4015
36682
(3012565) Volume of 24 hour Urine
61
126
4.89
27.83
2.5
2.5
ml
1696.7
2102.5
2.19
54
108
(3012516) Albumin [Mass/volume] in Urine
1416
10784
1.45
27.65
4.3
3.0
mg/l
291.4
276.3
0.06
1064
6680
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
479
2840
1.76
27.59
4.9
2.4
ml/min/173m2
49.0
69.4
31.34
288
1110
(3025941) Bacteria identified in Stool by Culture
341
1827
1.93
27.16
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1194
8829
1.47
27.09
1.7
1.5
nmol/l
18.7
20.3
2.58
1055
7461
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
127
444
2.91
27.03
1.8
1.5
—
—
—
0
0
(3036489) Thrombin time
259
1279
2.09
25.93
2.2
2.1
s
22.3
21.4
0.90
237
1137
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
107
349
3.11
25.72
1.8
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
49
91
5.43
25.21
2.8
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
67
162
4.18
25.17
1.4
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
67
163
4.16
24.97
2.8
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2656
22805
1.38
24.86
3.9
2.9
u/l
59.1
48.0
5.26
2519
21007
(46235355) HIV 1 and 2 tests - Meaningful Use set
794
5483
1.54
24.80
2.3
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
174
748
2.38
24.45
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
76
208
3.70
24.08
1.5
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
85
251
3.43
24.03
1.8
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
93
291
3.24
23.98
1.2
1.2
u/l
76.2
59.1
0.76
65
199
(3019225) pH of Specimen
573
3699
1.63
23.85
8.5
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
129
487
2.70
23.80
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
121
442
2.78
23.78
1.7
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
166
708
2.39
23.75
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
120
437
2.79
23.72
1.7
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
39
62
6.33
23.51
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
118
430
2.79
23.31
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
165
708
2.38
23.30
1.6
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
69
182
3.83
23.06
5.5
3.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
74
205
3.65
23.04
1.6
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
230
1137
2.08
22.97
6.6
5.4
mmol/l
1.3
1.3
0.52
201
1007
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
93
300
3.14
22.82
2.8
1.9
u/field
1.8
1.6
0.12
42
114
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
118
435
2.76
22.81
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
118
435
2.76
22.81
1.7
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
128
493
2.64
22.72
1.5
1.4
g/l
32.7
32.6
0.02
116
443
(3005988) Vibrio sp identified in Specimen by Organism specific culture
118
436
2.75
22.71
1.7
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
230
1142
2.07
22.70
2.5
2.1
ug/l
349.0
343.1
0.03
224
1073
(3037756) Immunofixation for Serum or Plasma
158
674
2.39
22.61
1.5
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
984
7226
1.46
22.51
4.3
3.6
ng/l
303.3
464.9
1.18
790
5775
(40768806) Pleura Pathology biopsy report
108
383
2.86
22.45
1.5
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
117
438
2.71
21.97
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
378
2236
1.75
21.81
1.5
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
68
185
3.72
21.76
2.6
1.8
min
503.6
500.7
0.07
54
129
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1071
8037
1.43
21.70
1.8
1.7
pmol/l
16036080.9
35634524.4
0.58
898
6592
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
38
64
5.98
21.66
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
110
402
2.78
21.63
5.5
21.7
mmol/l
7.3
7.4
0.22
91
327
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
60
150
4.04
21.60
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
60
150
4.04
21.60
1.6
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
401
2419
1.72
21.57
3.0
2.6
g/l
10.3
10.6
0.69
376
2181
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3710
34038
1.44
21.27
33.1
12.4
ml/min/173m2
68.7
80.4
125.19
3354
27902
(3013727) Leukocytes other/100 leukocytes in Blood
51
114
4.51
21.22
3.3
3.7
%
57.9
53.7
0.61
51
109
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
136
558
2.48
21.21
1.6
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
739
5193
1.50
20.95
22.0
26.8
inr
1.3
1.4
2.56
140
727
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
211
1046
2.07
20.92
1.6
1.5
titre
78.8
308.5
1.83
13
47
(3036525) Urea [Moles/time] in 24 hour Urine
20
0
+∞
20.84
3.5
0.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
92
312
2.99
20.75
2.8
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
394
2397
1.70
20.52
4.4
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
84
272
3.13
20.51
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
88
293
3.04
20.49
2.3
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
101
364
2.81
20.41
2.8
3.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
55
135
4.11
20.31
1.1
1.1
u/l
111.3
83.2
0.70
44
100
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
124
498
2.53
20.24
1.5
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
113
434
2.64
20.21
1.5
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
43
88
4.92
19.89
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
163
749
2.22
19.65
1.7
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
82
269
3.08
19.60
2.7
2.1
ml
731.6
575.7
2.89
63
163
(3012898) Urea [Moles/volume] in Urine
19
15
12.71
19.43
1.6
1.3
mmol/l
102.1
205.7
2.06
13
15
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
168
786
2.18
19.37
1.6
1.5
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
54
136
4.01
19.28
1.1
1.1
u/l
44.4
26.5
0.69
41
98
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
62
173
3.62
19.16
1.7
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
3024
27019
1.34
19.02
4.7
3.9
mm/h
18.7
11.9
57.58
2813
24808
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
67
198
3.42
18.99
1.6
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
320
1879
1.75
18.91
1.7
1.9
g/l
1.2
1.4
1.81
300
1692
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
90
318
2.87
18.89
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
231
1228
1.93
18.81
2.6
2.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
64
185
3.49
18.76
3.0
1.6
u/field
3.2
2.9
0.11
42
133
(3020891) Body temperature
267
1493
1.84
18.59
6.5
4.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
39
78
5.03
18.53
1.4
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
203
1039
2.00
18.45
4.7
3.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
242
1317
1.88
18.35
4.6
3.6
mmol/l
1.3
1.4
0.22
231
1302
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61
174
3.54
18.26
1.7
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
47
113
4.19
17.87
1.3
1.4
%
2.9
3.1
0.02
40
95
(3011648) Oxygen content in Venous blood
74
245
3.05
17.45
3.3
2.1
%
10.2
10.8
0.65
74
245
(3029634) Reagin Ab [Titer] in Serum by VDRL
102
402
2.57
17.36
2.1
1.8
—
3.6
—
0
8
(3019150) Specific gravity of Urine by Refractometry
1021
7858
1.38
17.31
7.0
3.7
kg/l
1.0
1.0
0.20
193
1176
(3012441) Differential panel - Pleural fluid
97
374
2.63
17.26
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
193
995
1.98
17.20
3.0
2.1
u/l
5295.2
5306.2
0.00
88
403
(40761511) CBC panel - Blood by Automated count
4011
37727
1.44
16.62
31.9
12.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
89
337
2.67
16.44
1.2
1.3
u/l
578.1
318.6
0.83
82
321
(3002385) Erythrocyte distribution width [Ratio]
3277
29878
1.32
16.38
39.9
16.1
%
14.3
13.7
72.02
3231
29160
(3022145) Colonoscopy Study observation
566
3957
1.49
16.19
1.4
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
234
1321
1.81
15.81
1.8
2.1
g/l
4.0
3.8
1.61
165
935
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
234
1322
1.81
15.77
1.8
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
234
1322
1.81
15.77
1.8
2.1
g/l
7.8
7.3
2.93
170
983
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
50
138
3.65
15.75
1.3
1.4
%
60.8
64.3
0.29
40
112
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
170
865
2.00
15.75
1.4
1.6
g/l
0.3
0.2
2.09
165
817
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
220
1224
1.84
15.59
1.9
2.1
g/l
10.7
10.2
0.98
193
1029
(3045414) Leukocytes [Presence] in Urine
267
1588
1.72
15.08
2.5
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
477
3275
1.51
14.86
3.2
2.7
ng/l
249.5
191.7
2.25
439
2965
(40768797) Stomach Pathology biopsy report
667
4889
1.42
14.82
1.3
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
86
338
2.57
14.78
1.3
1.4
mmol/l
6.2
6.2
0.01
80
312
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1810
15413
1.28
14.63
2.2
2.0
pmol/l
92.3
94.5
1.23
1082
7985
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
135
652
2.10
14.44
1.6
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
2849
25686
1.28
14.38
4.6
3.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
68
241
2.85
14.28
1.9
1.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
43
5.84
13.98
2.1
1.2
ng/l
194.4
80.4
2.33
25
43
(3019977) pH of Arterial blood
59
196
3.04
13.91
2.7
2.5
ph
7.4
7.4
1.59
21
68
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
170
904
1.91
13.89
1.4
1.6
g/l
1.2
1.2
0.16
164
851
(3051611) Lipemic interference index of Serum or Plasma
85
345
2.49
13.69
5.1
3.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
39
100
3.92
13.67
7.4
6.2
mmol/l
23.4
25.3
1.79
39
91
(3003181) Sodium [Moles/volume] in Urine
122
583
2.12
13.44
1.5
1.3
mmol/l
59.9
67.9
1.22
98
477
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
33
76
4.37
13.31
3.8
1.6
ug/l
20.5
2.1
0.84
27
43
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
471
3308
1.47
13.07
2.5
2.3
ug/l
5.8
7.0
1.20
407
2876
(3014148) Varicella zoster virus Ab [Titer] in Serum
80
324
2.49
12.97
1.1
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
25
47
5.34
12.75
1.2
1.3
%
16.6
7.3
0.96
17
19
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4065
38685
1.39
12.51
17.9
9.8
u/l
24.1
25.9
6.63
3942
37081
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
162
881
1.87
12.40
3.3
2.2
ug/min
178.9
76.1
1.61
116
513
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
54
183
2.97
12.34
1.5
1.6
u/l
8.1
6.6
0.23
32
87
(3045424) Erythrocytes [Presence] in Urine
116
564
2.08
12.25
1.8
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
93
414
2.27
12.24
1.6
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
152
820
1.88
11.94
8.2
6.1
mmol/l
11.2
11.1
0.20
136
732
(3018572) Chloride [Moles/volume] in Blood
152
821
1.88
11.90
8.2
6.1
mmol/l
105.7
105.3
0.42
136
733
(3023199) Leukocytes [#/volume] in Pleural fluid
98
452
2.19
11.85
1.5
1.4
e6/l
923.6
1918.3
3.84
69
339
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
208
1237
1.71
11.80
1.8
2.1
g/l
3.2
3.1
1.56
167
958
(3023487) Leukocytes [#/volume] in Peritoneal fluid
36
98
3.69
11.64
1.6
1.8
e6/l
886.4
8381.8
0.48
22
70
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
15
5
30.09
11.63
5.9
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
49
163
3.03
11.58
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
59
223
2.67
11.06
1.1
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
191
1133
1.71
10.96
2.2
2.2
g/l
0.9
1.0
0.17
169
970
(3043409) Potassium [Moles/volume] in Arterial blood
192
1143
1.71
10.88
5.2
3.8
mmol/l
4.1
3.9
3.50
162
1072
(3044242) Glucose [Moles/volume] in Arterial blood
53
192
2.78
10.78
2.1
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
15
7
21.49
10.67
1.3
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
31
81
3.85
10.64
1.6
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
32
86
3.74
10.56
1.3
1.7
e6/l
2111.3
10934.0
1.33
13
53
(3017354) Segmented neutrophils/100 leukocytes in Blood
77
340
2.29
10.39
2.9
3.3
%
64.5
55.8
2.45
43
202
(3044927) Protein electrophoresis panel - Urine
71
304
2.36
10.28
1.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2332
21000
1.22
10.04
3.1
2.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
169
998
1.72
9.89
1.8
2.1
g/l
0.0
0.0
0.35
158
913
(3022493) Free Hemoglobin [Mass/volume] in Plasma
40
130
3.09
9.88
1.7
5.8
mg/l
72.8
75.9
0.07
33
90
(3042631) Mycobacterium sp identified in Specimen
100
500
2.02
9.87
2.2
2.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
215
1353
1.62
9.86
2.0
1.8
u/l
37.6
39.0
0.53
196
1185
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
66
279
2.39
9.85
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
66
279
2.39
9.85
1.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
66
279
2.39
9.85
1.6
1.5
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
13
5
26.06
9.80
1.5
1.4
mmol/24h
1.7
2.7
—
13
5
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
79
362
2.20
9.78
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
61
251
2.45
9.66
1.6
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
171
1021
1.70
9.62
1.5
1.4
ug/g
242.6
276.6
1.20
107
589
(3028308) Erythrocytes [#/volume] in Pleural fluid
86
412
2.11
9.53
1.4
1.4
e6/l
37488.1
69875.3
0.62
51
250
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
34
104
3.29
9.28
3.3
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
34
104
3.29
9.28
3.3
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
792
6372
1.29
9.28
1.5
1.4
g/l
2.6
2.4
0.97
515
3731
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
97
491
2.00
9.28
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4183
40303
1.36
9.26
47.8
19.6
e9/l
252.7
246.1
7.41
4092
39141
(3045788) Cell count panel - Pleural fluid
76
353
2.17
9.13
1.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1637
14323
1.22
9.12
6.9
5.3
ug/l
12.4
3.4
3.50
1469
12741
(3024731) MCV [Entitic volume]
4183
40320
1.35
9.08
47.6
19.6
fl
91.2
91.2
0.43
4120
39648
(3035941) MCH [Entitic mass]
4183
40320
1.35
9.08
47.5
19.5
pg
30.1
30.4
19.93
4119
39648
(3017732) Neutrophils [#/volume] in Blood
337
2381
1.45
9.05
3.4
3.0
e9/l
4.5
4.1
1.43
263
1815
(3026361) Erythrocytes [#/volume] in Blood
4183
40323
1.35
9.05
47.7
19.6
e12/l
4.2
4.5
178.54
4081
39028
(3000963) Hemoglobin [Mass/volume] in Blood
4184
40336
1.35
9.03
48.1
19.7
g/l
125.2
135.5
251.89
4126
39668
(3010813) Leukocytes [#/volume] in Blood
4183
40330
1.35
8.98
47.8
19.7
e9/l
7.2
6.8
21.16
4085
39032
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
170
1035
1.67
8.92
1.8
2.0
g/l
35.8
38.0
4.89
152
879
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
99
513
1.95
8.87
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3462
32638
1.23
8.76
30.8
14.5
%
36.4
39.5
44.32
2222
22493
(21494890) Protein electrophoresis panel - 24 hour Urine
63
276
2.30
8.72
1.7
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
57
239
2.40
8.70
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
538
4140
1.34
8.67
1.6
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
790
9628
0.78
8.64
1.7
1.6
mmol/l
1.5
1.3
4.91
672
8040
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
154
924
1.69
8.55
1.9
2.1
g/l
0.0
0.0
0.00
143
843
(3035880) pH of Pleural fluid
51
205
2.50
8.53
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
43
159
2.72
8.49
1.7
1.6
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
27
77
3.52
8.23
1.9
2.2
mmol/l
7.8
7.7
0.04
18
44
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
151
911
1.68
8.23
1.9
2.1
g/l
0.0
0.0
0.00
141
842
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
69
323
2.15
8.17
1.6
1.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
48
194
2.49
7.96
2.0
2.2
umol/l
16.5
26.1
—
6
17
(3017446) Testosterone [Moles/volume] in Serum or Plasma
377
2782
1.39
7.94
2.3
2.1
nmol/l
7.6
12.3
18.11
311
2432
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
27
79
3.43
7.93
1.1
1.3
—
—
—
0
0
(44790049)
75
370
2.04
7.77
1.6
1.4
—
—
—
0
0
(44790047)
75
370
2.04
7.77
1.6
1.4
—
—
—
0
0
(44806118)
75
370
2.04
7.77
1.6
1.4
—
—
—
0
0
(44790048)
75
370
2.04
7.77
1.6
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
72
350
2.07
7.75
1.6
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
556
4375
1.31
7.63
1.3
1.3
titre
597.1
525.7
0.31
97
937
(21494755) Public health laboratory ask at order entry panel
174
2634
0.65
7.31
1.3
1.3
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
7
0
+∞
7.29
4.4
0.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
41
161
2.56
7.25
1.4
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
41
161
2.56
7.25
1.4
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
41
161
2.56
7.25
1.4
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
41
161
2.56
7.25
1.4
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
67
326
2.07
7.23
1.1
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
20
51
3.93
7.15
2.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
155
983
1.60
6.99
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
63
304
2.09
6.96
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
142
883
1.63
6.94
1.6
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
155
986
1.59
6.91
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
62
300
2.08
6.81
2.5
2.5
e9/l
0.8
1.1
2.42
38
177
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
11
17
6.48
6.77
1.0
1.5
%
32.3
29.8
—
6
10
(3016038) Potassium [Moles/volume] in Urine
50
223
2.26
6.72
1.4
1.2
mmol/l
32.7
34.3
0.20
44
190
(42529406) Shigella sp [Presence] in Stool by Culture
155
996
1.58
6.63
1.3
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
49
219
2.25
6.57
2.2
2.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
41
170
2.42
6.50
1.3
1.2
u/l
18.8
20.5
0.13
35
140
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
74
389
1.92
6.47
1.4
1.3
nmol/l
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
134
837
1.62
6.46
1.3
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
42
177
2.39
6.44
1.3
1.2
u/l
82.9
81.2
0.04
35
148
(3024980) IgG subclass 4 [Mass/volume] in Serum
89
499
1.80
6.37
2.7
1.7
g/l
1.0
0.8
0.56
72
388
(3047185) IgG [Mass/volume] in Urine
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
76
409
1.87
6.21
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
134
851
1.59
6.06
1.3
1.2
titre
82.7
96.3
0.36
15
59
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
129
826
1.58
5.66
2.0
1.9
mg/l
11.9
10.6
0.81
120
753
(3051387) C reactive protein [Mass/volume] in Capillary blood
130
838
1.57
5.55
5.0
3.2
mg/l
33.4
28.1
0.81
89
528
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
50
243
2.07
5.50
1.3
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
36
153
2.36
5.46
2.8
2.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
18
5.57
5.32
1.2
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
40
181
2.22
5.27
1.6
2.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
80
462
1.74
5.25
1.3
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
38
169
2.26
5.22
2.2
2.4
%
102.1
96.3
0.39
38
162
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
5
0
+∞
5.21
5.6
0.0
umol/l
738.8
—
—
5
0
(3014271) Vancomycin [Susceptibility]
41
189
2.18
5.17
2.5
3.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
46
222
2.08
5.17
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
62
333
1.87
5.16
1.3
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
26
97
2.69
5.16
2.9
2.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
88
527
1.68
5.08
1.4
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
73
415
1.77
5.07
1.3
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
42
198
2.13
5.02
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
118
1772
0.66
4.86
1.3
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
46
229
2.02
4.79
2.3
2.3
%
10.7
13.3
0.79
16
105
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
28
113
2.49
4.78
1.1
1.1
miu/ml
1675.8
1639.0
0.05
28
113
(3036603) Volume of Urine
41
196
2.10
4.75
1.8
1.5
ml
1618.6
1848.6
0.62
16
46
(3048689) Calprotectin [Mass/mass] in Stool
492
4045
1.24
4.72
2.4
2.2
ug/g
174.3
139.5
1.01
387
3163
(21494814) CD8 cells/100 lymphocytes in Specimen
29
121
2.41
4.63
3.0
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
33
148
2.24
4.49
1.2
1.1
—
—
—
0
0
(4062490)
56
307
1.83
4.43
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
199
2669
0.73
4.37
1.6
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
130
891
1.47
4.26
1.1
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
82
507
1.63
4.25
1.2
1.2
u/ml
1.9
3.8
1.30
33
162
(3001019) Free T4 and TSH panel - Serum or Plasma
99
1492
0.66
4.20
1.9
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
90
572
1.58
4.18
1.8
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
41
3.42
4.18
2.6
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
98
640
1.54
4.06
1.6
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
18
63
2.86
4.05
1.3
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
29
129
2.26
4.05
1.5
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
29
129
2.26
4.05
1.5
1.7
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
7
7
10.01
4.01
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
92
595
1.56
3.98
1.6
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
29
130
2.24
3.98
1.5
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
148
1058
1.41
3.91
1.7
1.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
13
38
3.43
3.90
6.2
1.9
u/field
0.2
0.6
1.62
13
38
(3028192) IgG subclass 2 [Mass/volume] in Serum
54
306
1.77
3.88
1.5
1.4
g/l
2.8
3.0
0.27
42
220
(3024139) IgG subclass 3 [Mass/volume] in Serum
54
306
1.77
3.88
1.5
1.4
g/l
0.5
0.4
0.34
42
219
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
92
599
1.55
3.88
1.3
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
22
88
2.51
3.87
1.3
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
54
307
1.77
3.84
1.5
1.4
g/l
7.9
6.6
1.72
42
222
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
54
307
1.77
3.84
1.4
1.5
—
—
—
0
0
(4268621)
59
346
1.71
3.77
2.3
2.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
40
208
1.93
3.76
1.3
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
29
134
2.17
3.72
2.7
2.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
16
5.63
3.65
3.0
4.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
100
673
1.50
3.64
3.6
1.5
nmol/l
1.0
0.8
2.62
88
567
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
78
497
1.58
3.63
1.2
1.2
u/ml
3.5
5.1
0.97
36
212
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
13
40
3.26
3.62
1.2
1.3
ng/l
82.8
64.5
—
6
26
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
85
553
1.55
3.62
1.7
1.3
u/l
56.0
37.5
0.29
76
473
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
40
211
1.90
3.62
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
121
848
1.44
3.59
3.2
2.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
257
2031
1.28
3.51
3.2
3.3
pmol/l
4.2
4.5
5.95
235
1784
(4024509)
58
347
1.68
3.48
1.8
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
20
81
2.48
3.46
1.2
1.4
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
25
113
2.22
3.41
1.1
1.3
ug/l
145.6
221.2
0.25
12
61
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
19
4.74
3.23
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
833
7430
1.15
3.16
1.3
1.3
u/ml
1.0
1.9
2.98
224
1908
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
250
1997
1.27
3.16
2.5
2.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
28
137
2.05
3.16
1.3
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
75
491
1.54
3.15
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
18
73
2.47
3.12
1.7
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
62
390
1.60
3.10
1.5
1.5
%
66.3
57.8
0.91
43
235
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
52
313
1.67
3.09
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
77
510
1.52
3.08
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
58
360
1.62
3.06
1.3
1.4
mosm/kgh2o
279.5
278.0
0.19
48
271
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3425
35285
0.89
3.06
4.5
4.4
mmol/l
1.4
1.5
12.86
3107
32154
(3024869) Neuronal Ab [Presence] in Serum
17
68
2.51
3.03
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
25
119
2.11
3.03
1.6
1.6
umol/l
87.3
148.2
0.96
13
66
(3023410) Appearance of Cerebral spinal fluid
52
316
1.65
2.99
1.5
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
24
114
2.11
2.93
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
121
884
1.38
2.91
1.2
1.3
miu/ml
207.7
224.7
0.18
41
419
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
30
3.34
2.90
1.2
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
16
64
2.51
2.87
2.1
3.6
ng/l
156.5
156.4
—
8
39
(3052592) Norovirus Ag [Presence] in Stool
16
64
2.51
2.87
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
74
496
1.50
2.83
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
57
361
1.59
2.80
1.9
2.3
umol/l
6.7
6.0
0.16
43
253
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
38
216
1.77
2.79
2.1
2.5
e6/l
422.9
497.1
0.66
32
181
(3023323) Follitropin [Units/volume] in Serum or Plasma
161
1237
1.31
2.79
1.6
1.4
iu/l
33.8
27.1
1.41
143
1043
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3543
36376
0.89
2.78
4.9
4.9
mmol/l
2.6
2.7
12.43
3226
33190
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
71
474
1.51
2.77
2.4
2.0
mg/l
35.4
24.8
0.59
19
110
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
6
8.34
2.75
1.2
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
12
42
2.86
2.74
1.7
2.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
104
2.12
2.74
1.9
1.8
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
14
5.01
2.72
1.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
65
428
1.53
2.71
1.9
1.5
mu/l
106.0
57.4
0.45
59
380
(3032057) Clostridioides difficile [Presence] in Stool
16
66
2.43
2.70
2.3
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
70
469
1.50
2.70
1.1
1.1
%
115.8
114.7
0.11
61
417
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
74
502
1.48
2.68
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3462
35567
0.90
2.67
4.6
4.4
mmol/l
4.5
4.6
9.40
3161
32649
(3014891) Appearance of Pleural fluid
13
49
2.66
2.62
1.8
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
265
2182
1.23
2.61
1.2
1.2
iu/ml
123.4
135.8
0.19
91
801
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
221
1.73
2.60
2.7
2.3
e6/l
459.4
648.7
1.27
19
94
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
84
1180
0.71
2.59
1.5
1.6
mg/l
5.2
3.5
0.82
67
822
(3017509) Phencyclidine [Presence] in Urine
8
20
4.00
2.56
1.6
1.3
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
5
7
7.15
2.55
1.4
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
12
44
2.73
2.54
1.7
1.4
ug/l
129.3
122.3
0.06
12
37
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
101
2.08
2.52
1.1
1.1
%
91.8
86.1
0.41
12
59
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
65
437
1.49
2.49
1.2
1.1
g/l
1.6
1.5
0.70
60
387
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
45
2.67
2.45
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
22
110
2.00
2.40
1.4
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
12
5.00
2.40
1.2
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
27
3.34
2.39
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1240
11511
1.11
2.36
5.1
4.6
%
23.8
21.8
3.78
712
5895
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
32
183
1.75
2.35
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
330
2808
1.19
2.34
2.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
62
419
1.49
2.33
1.2
1.2
—
—
—
0
0
(4306422)
70
486
1.45
2.31
1.2
1.2
—
—
—
0
0
(44806420)
21
105
2.00
2.30
2.5
2.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
35
2.86
2.30
2.2
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
58
388
1.50
2.30
3.7
3.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
22
112
1.97
2.30
1.2
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
41
2.69
2.27
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
32
185
1.73
2.27
5.4
3.5
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
15
66
2.28
2.24
1.1
1.2
%
76.8
69.1
—
6
21
(40757373) Influenza virus identified in Isolate
15
66
2.28
2.24
1.3
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
39
240
1.63
2.22
1.1
1.2
titre
84.3
148.7
—
7
45
(4198724)
20
100
2.00
2.20
1.4
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
96
712
1.36
2.18
1.9
1.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
8
24
3.34
2.18
3.3
3.8
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
15
67
2.24
2.17
1.3
1.2
%
100.5
74.8
—
6
22
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
81
585
1.39
2.17
2.0
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
43
276
1.56
2.08
1.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
10
5.00
2.07
1.2
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
31
2.91
2.07
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
82
2.08
2.06
1.0
1.5
—
—
—
0
0
(4211845)
33
200
1.65
2.01
5.3
3.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
98
741
1.33
1.99
1.3
1.4
e6/l
4.8
21.3
1.44
75
577
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
98
741
1.33
1.99
1.3
1.5
e6/l
240.6
1180.6
1.66
81
611
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
7
21
3.34
1.96
9.9
8.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
11
4.55
1.94
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
124
973
1.28
1.93
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
39
2.57
1.92
2.2
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
15
71
2.12
1.92
1.9
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
165
1344
1.24
1.88
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
119
933
1.28
1.88
1.4
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
72
2.09
1.86
1.2
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
20
107
1.87
1.86
1.3
1.2
g/l
38.9
40.1
—
10
53
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
19
100
1.90
1.85
3.0
2.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
19
100
1.90
1.85
1.6
1.8
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
17
3.53
1.83
1.0
1.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
28
167
1.68
1.83
1.1
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
20
108
1.86
1.81
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
20
352
0.57
1.80
1.0
1.0
u/ml
4.2
0.4
—
6
89
(3004716) Salmonella sp identified in Stool by Organism specific culture
194
1620
1.21
1.76
1.4
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
102
1.87
1.76
1.1
1.3
%
83.0
81.7
—
10
61
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
57
404
1.42
1.76
1.9
1.4
pmol/l
556.3
284.8
0.60
44
311
(3010144) Erythrocytes [#/volume] in Synovial fluid
47
322
1.46
1.73
1.4
1.3
e6/l
13180.9
105180.6
1.86
34
228
(3006270) Folate [Moles/volume] in Blood
49
339
1.45
1.72
1.2
1.2
nmol/l
327.1
348.9
0.24
35
282
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
13
3.85
1.71
1.0
1.2
nmol/l
263.6
239.2
—
5
13
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
19
103
1.85
1.71
1.4
1.2
%
99.2
98.2
0.04
19
97
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
333
2920
1.15
1.69
1.9
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
125
1002
1.25
1.68
1.6
1.6
iu/ml
0.5
14.3
1.07
30
217
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
183
2181
0.83
1.67
1.3
1.3
au/ml
31.5
55.8
—
9
96
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
180
1.61
1.66
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
73
548
1.34
1.62
1.1
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
108
856
1.27
1.61
1.4
1.3
mg/l
471.7
530.1
0.83
101
811
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
425
0.63
1.59
1.1
1.1
u/ml
7.1
3.8
—
10
162
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
32
2.50
1.59
1.5
2.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
46
320
1.44
1.59
1.5
1.4
%
22.2
31.3
1.11
34
193
(4034850)
97
1226
0.79
1.56
16.2
10.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
10
44
2.28
1.53
1.1
1.4
nmol/l
7.4
492113.5
—
10
38
(3009214) Lutropin [Units/volume] in Serum or Plasma
107
854
1.26
1.52
1.7
1.4
u/l
14.2
9.8
1.57
101
692
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
33
217
1.52
1.51
1.8
1.6
mmol/l
8.0
7.9
0.14
18
137
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
885
8254
1.09
1.50
3.4
3.2
ug/l
1.2
0.8
6.35
633
5713
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
16
86
1.86
1.50
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
16
86
1.86
1.50
2.7
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
37
537
0.69
1.49
1.0
1.1
u/ml
2.2
5.3
2.55
18
275
(3029396) Erythrocyte agglutination [Presence] in Blood
13
65
2.00
1.48
3.1
3.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
47
334
1.41
1.47
1.2
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
46
327
1.41
1.44
3.3
2.9
mg/l
143.8
29.2
1.19
40
252
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
5
16
3.13
1.44
1.4
1.6
mg/l
2.0
0.6
—
5
11
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
5
16
3.13
1.44
1.4
1.6
mg/l
0.2
0.7
—
5
9
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
5
16
3.13
1.44
1.4
1.6
mg/l
0.3
1.1
—
5
9
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
5
16
3.13
1.44
1.4
1.6
mg/l
0.8
1.6
—
5
9
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
37
253
1.47
1.42
1.1
1.2
u/ml
5.0
2.1
—
5
13
(3009871) Measles virus Ab [Titer] in Serum
16
88
1.82
1.41
1.9
1.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
20
326
0.61
1.40
6.2
4.9
u/ml
163.4
79.5
—
6
88
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
29
2.42
1.39
2.1
2.2
—
—
—
0
0
(3000492) Spirometry study
287
3245
0.88
1.38
1.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
152
1275
1.20
1.38
1.8
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
84
1060
0.79
1.37
1.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
5
17
2.94
1.36
1.4
1.6
mg/l
1.8
0.4
—
5
9
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
36
514
0.70
1.36
1.0
1.1
u/ml
0.3
1.3
2.06
14
220
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
594
0.72
1.34
1.1
1.1
u/ml
6.2
1.7
0.47
19
242
(3023420) DNA double strand Ab [Units/volume] in Serum
43
307
1.40
1.33
1.4
1.5
—
20.4
—
0
17
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
21
128
1.64
1.33
1.2
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
21
129
1.63
1.29
1.2
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
18
2.78
1.28
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
93
751
1.24
1.24
1.3
1.3
mmol/l
3.6
3.8
1.12
85
701
(3009466) Valproate [Moles/volume] in Serum or Plasma
61
467
1.31
1.24
7.3
4.6
umol/l
361.9
352.1
0.21
56
395
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
209
2394
0.87
1.24
2.3
2.4
au/ml
17.5
21.4
—
8
121
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
33
228
1.45
1.23
1.8
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
100
1.70
1.23
1.1
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
85
682
1.25
1.21
1.3
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
37
2.16
1.21
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
67
522
1.29
1.21
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
200
1740
1.16
1.20
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
101
828
1.22
1.19
1.5
1.9
iu/l
4.9
4.5
0.08
29
289
(4212803)
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(4094501)
78
968
0.80
1.15
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
159
1.51
1.11
1.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
159
1.51
1.11
1.1
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
31
2.26
1.10
1.1
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
7
32
2.19
1.08
1.6
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
32
2.19
1.08
1.4
2.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
43
321
1.34
1.07
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
511
5512
0.92
1.07
1.2
1.2
u/ml
18.1
13.0
0.27
180
2114
(3020491) Glucose [Moles/volume] in Blood
39
287
1.36
1.06
1.9
2.0
mmol/l
6.6
6.5
0.13
23
187
(3023419) Bacteria identified in Sputum by Culture
60
471
1.28
1.05
2.0
2.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3350
34044
0.94
1.04
4.2
3.9
mmol/l
1.4
1.3
12.32
3031
30793
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
356
3247
1.10
1.03
2.0
2.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2807
27473
1.05
1.03
4.2
3.9
pmol/l
14.9
14.9
0.82
2562
24732
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
37
272
1.36
1.02
1.1
1.2
u/ml
23.0
58.8
—
7
23
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
29
0.00
0.97
0.0
4.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
29
0.00
0.97
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
17
108
1.58
0.96
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
51
648
0.78
0.96
1.5
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
26
182
1.43
0.95
3.3
2.7
%
40.0
37.6
—
8
62
(3023430) Cat dander IgE Ab [Units/volume] in Serum
28
386
0.72
0.93
1.1
1.1
u/ml
1.5
4.7
—
10
157
(1002224) Polysomnography panel
104
1222
0.85
0.92
1.1
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
36
269
1.34
0.92
1.1
1.1
u/ml
92.4
76.8
—
5
9
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
78
1.67
0.91
1.3
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
36
270
1.34
0.90
1.4
1.5
u/ml
27.8
22.3
—
6
65
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
108
921
1.18
0.90
1.1
1.2
u/ml
34.8
46.4
—
10
56
(3021788) Differential panel - Synovial fluid
74
610
1.22
0.89
1.6
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
202
1.39
0.89
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
202
1.39
0.89
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
23
160
1.44
0.88
4.7
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
42
1.91
0.88
1.4
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
25
177
1.41
0.88
1.2
1.1
ratio
1.1
1.0
—
8
62
(3010726) Horse dander IgE Ab [Units/volume] in Serum
38
494
0.77
0.87
1.1
1.1
u/ml
2.1
2.4
—
8
121
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
43
1.86
0.87
1.3
1.5
—
—
—
0
0
(44806071)
6
30
2.00
0.87
1.2
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
548
5833
0.93
0.85
1.2
1.3
iu/ml
31.3
34.1
0.20
182
1762
(3022689) Creatine [Moles/volume] in Urine
16
104
1.54
0.84
1.7
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
263
2395
1.10
0.83
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
77
918
0.84
0.83
1.4
1.5
—
—
—
0
0
(44813793)
15
226
0.66
0.82
1.3
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
65
534
1.22
0.82
1.1
1.1
iu/ml
11.7
1194.9
0.55
11
113
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
13
81
1.61
0.81
1.2
1.4
ug/l
0.5
0.4
—
6
45
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
256
2806
0.91
0.81
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
176
1571
1.12
0.80
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
215
1.35
0.80
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
97
834
1.17
0.76
1.6
1.6
e6/l
38269.6
12877.1
1.17
78
594
(3034891) Synovial lining cells/100 cells in Synovial fluid
22
157
1.40
0.76
1.5
1.3
%
3.6
4.2
—
5
31
(4027681)
25
183
1.37
0.75
1.2
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
24
2.08
0.74
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
55
1.64
0.73
1.1
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
55
1.64
0.73
1.1
1.1
%
98.2
101.0
—
9
55
(3044009) aPTT.lupus sensitive (LA screen)
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
39
1.80
0.72
1.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
56
1.61
0.72
1.8
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
99
858
1.16
0.72
1.2
1.2
u/ml
6.2
7.6
0.14
16
145
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
58
480
1.21
0.71
1.4
1.3
mmol/l
7.3
7.4
0.14
41
348
(3019174) dRVVT (LA screen)
5
26
1.92
0.70
1.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
24
177
1.36
0.70
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
169
1.36
0.69
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
286
2645
1.09
0.68
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
97
845
1.15
0.67
1.1
1.2
u/ml
2.7
2.6
—
10
84
(3027456) Digoxin [Moles/volume] in Serum or Plasma
88
763
1.16
0.65
3.5
3.1
nmol/l
0.8
0.8
0.02
57
577
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
78
1.54
0.65
3.4
2.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
29
1.72
0.64
1.2
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
29
1.72
0.64
1.4
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
64
543
1.18
0.62
1.5
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
71
1.55
0.62
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
32
253
1.27
0.61
2.8
2.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
25
191
1.31
0.60
1.4
1.2
nmol/l
136.4
136.2
0.01
25
191
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
18
132
1.37
0.57
1.1
1.1
%
113.3
89.4
—
10
101
(44816559) Phosphatidylethanol [Mass/volume] in Blood
51
603
0.84
0.56
1.5
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
86
0.58
0.56
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
32
257
1.25
0.55
1.5
1.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
23
177
1.30
0.54
2.0
2.2
ug/min
122.3
73.2
—
6
41
(4133840)
12
82
1.46
0.54
1.1
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
195
1.28
0.54
3.7
4.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
79
693
1.14
0.53
1.1
1.2
u/ml
1.4
4.9
—
6
51
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
75
855
0.88
0.53
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
215
0.74
0.52
1.0
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
31
250
1.24
0.52
1.4
1.3
promille
1.5
1.3
0.34
25
191
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
98
0.61
0.52
1.5
1.6
ug/l
9.0
8.8
—
6
98
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
20
153
1.31
0.50
1.2
1.1
u/ml
—
34.6
—
0
13
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3358
33253
1.03
0.49
4.9
4.6
mu/l
2.0
2.1
0.69
3081
30112
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
20
257
0.78
0.49
1.0
1.0
ng/l
340.6
311.8
0.25
14
165
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
20
257
0.78
0.49
1.0
1.0
ng/l
52.0
44.7
0.42
14
162
(3041806) Other cells [#/volume] in Blood by Manual count
7
108
0.65
0.48
1.3
1.7
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
20
256
0.78
0.47
1.0
1.0
ng/l
668.1
668.4
0.00
15
159
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
211
0.76
0.47
7.4
6.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
34
281
1.21
0.47
1.4
1.3
mmol/l
11.4
11.5
—
6
59
(1617658) Protocol used for examination of sentinel lymph nodes
20
255
0.78
0.46
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
49
420
1.17
0.46
3.0
2.9
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
94
1.38
0.46
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
95
1.37
0.43
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
57
1.40
0.42
1.8
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
95
0.63
0.42
1.0
1.1
—
—
—
0
0
(4015189)
13
96
1.36
0.41
1.2
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
98
1078
0.91
0.41
1.8
1.7
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
1.2
—
0
9
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
27
326
0.83
0.40
1.3
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.3
—
0
9
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
40
465
0.86
0.40
1.2
1.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
8.7
—
0
13
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
88
1.36
0.40
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
35
1.43
0.39
1.6
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
35
1.43
0.39
3.0
2.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
10
71
1.41
0.39
6.2
6.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
124
1.29
0.38
1.1
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
1.4
2.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
98
1.33
0.37
1.2
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
5
37
1.35
0.37
1.6
1.4
—
823.2
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
68
755
0.90
0.36
1.2
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
180
1.22
0.35
1.0
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
42
1.43
0.35
2.2
3.3
—
—
—
0
0
(4010399)
268
2553
1.05
0.34
1.4
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
45
1.33
0.33
5.0
5.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
45
1.33
0.33
2.5
2.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
35
303
1.16
0.32
1.1
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
107
992
1.08
0.31
1.8
1.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
14
110
1.27
0.31
1.0
1.1
—
0.1
—
0
5
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
480
4645
1.04
0.31
4.4
4.5
%
32.9
32.9
0.00
359
3013
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
34
389
0.87
0.30
1.9
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
129
1.24
0.30
1.5
2.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
16
130
1.23
0.28
1.1
1.3
nmol/l
17.6
32.5
—
10
114
(3021387) Prolactin [Units/volume] in Serum or Plasma
117
1095
1.07
0.28
1.7
1.6
mu/l
294.2
291.9
0.04
104
986
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
76
1.32
0.28
29.1
7.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
11
85
1.29
0.28
1.3
2.4
e6/l
160.0
1063.8
—
6
40
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
66
1.21
0.26
1.9
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
39
347
1.12
0.26
1.7
1.4
ug/l
3.3
4.4
0.56
30
308
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
171
0.82
0.26
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
127
0.79
0.25
1.2
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
52
571
0.91
0.25
1.5
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
76
1.18
0.24
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
94
880
1.07
0.24
1.3
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
180
1.17
0.23
1.1
1.1
u/l
1.1
1.1
—
9
98
(3025577) Chromium [Mass/volume] in Blood
21
243
0.86
0.23
1.9
2.0
ug/l
2.1
2.2
0.08
15
204
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
40
1.25
0.22
1.6
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
19
163
1.17
0.21
1.1
1.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
12
0.00
0.21
0.0
4.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
33
296
1.12
0.21
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
102
0.78
0.21
1.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
3.5
—
0
13
(3015171) Extractable nuclear Ab [Units/volume] in Serum
133
1268
1.05
0.20
1.2
1.2
u/ml
0.2
1.2
—
7
120
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
48
1.25
0.20
2.5
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
113
0.80
0.20
1.7
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
50
1.20
0.19
1.2
2.1
umol/l
11.0
18.4
—
6
50
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
471
4817
0.98
0.19
15.0
6.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
571
5599
1.02
0.19
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
95
1002
0.95
0.18
1.4
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
53
1.13
0.18
2.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
65
692
0.94
0.17
1.5
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
22
247
0.89
0.17
1.3
1.4
pmol/l
85.3
175.7
0.35
11
80
(3005033) Fetal Nuchal fold Thickness US
53
568
0.93
0.17
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
494
4845
1.02
0.17
1.5
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
19
167
1.14
0.16
1.4
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
69
1.16
0.16
1.6
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
70
1.14
0.16
1.1
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
587
0.94
0.16
1.6
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
168
1.13
0.15
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
379
3869
0.98
0.15
1.7
1.7
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
14
121
1.16
0.15
1.9
2.3
ug/l
1.1
1.2
0.03
14
113
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
66
697
0.95
0.14
1.5
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
24
217
1.11
0.14
1.4
1.5
g/l
1.0
0.9
0.43
24
217
(3029075) Extractable nuclear Ab panel - Serum
7
89
0.79
0.14
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
202
0.89
0.14
1.2
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
66
696
0.95
0.14
1.5
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
208
1.11
0.14
1.1
1.1
iu/ml
6.6
12.3
—
5
51
(3036071) Salmonella sp Ab [Titer] in Serum
9
109
0.83
0.13
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
190
1.11
0.12
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
21
190
1.11
0.12
1.7
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
85
1.18
0.12
29.1
6.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
45
425
1.06
0.11
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
183
1787
1.03
0.10
2.0
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
21
192
1.09
0.10
1.1
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
239
0.92
0.10
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
239
0.92
0.10
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
239
0.92
0.10
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
97
1002
0.97
0.10
2.2
2.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
29
310
0.94
0.10
1.2
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
10
87
1.15
0.09
1.2
1.2
%
20.8
31.3
—
5
60
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
248
0.93
0.09
1.3
1.4
u/ml
2.5
1.2
—
10
116
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
67
696
0.96
0.09
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
96
989
0.97
0.09
1.5
2.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
54
1.11
0.09
1.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
208
2042
1.02
0.08
1.3
1.3
u/ml
376.6
213.7
1.15
188
1883
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
107
1.12
0.08
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
58
1.03
0.08
1.2
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
236
0.93
0.08
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
236
0.93
0.08
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
236
0.93
0.08
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
98
1007
0.97
0.08
2.2
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
370
3745
0.99
0.08
1.7
1.7
%
1.6
1.5
1.32
326
3264
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
348
0.95
0.08
1.5
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
75
1.07
0.07
1.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
83
0.84
0.07
1.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
18
167
1.08
0.06
1.6
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
90
0.89
0.06
1.4
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
183
0.93
0.06
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
142
0.92
0.06
1.5
2.0
ug/l
20.5
75.1
0.50
13
129
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
102
0.88
0.06
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
197
1.07
0.06
10.8
11.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
84
860
0.98
0.06
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
74
758
0.98
0.05
1.6
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
46
445
1.03
0.05
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
98
999
0.98
0.05
2.2
2.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
130
0.92
0.04
2.3
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
38
367
1.04
0.04
1.7
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3528
35314
1.00
0.03
4.9
4.6
mmol/l
6.0
6.0
3.00
3175
31896
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
129
0.93
0.03
1.2
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
91
924
0.98
0.03
2.2
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
44
451
0.98
0.03
1.3
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
22
212
1.04
0.02
1.7
1.4
mmol/l
5.3
5.9
1.77
22
199
(4146454)
43
421
1.02
0.02
2.9
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
77
780
0.99
0.02
2.3
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1188
11859
1.00
0.02
3.3
2.9
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
10
93
1.08
0.02
1.0
1.1
u/ml
1.1
2.6
—
5
49
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3339
33409
1.00
0.02
6.9
5.8
mmol/mol
40.5
39.8
3.62
3070
30598
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
44
432
1.02
0.01
1.0
1.1
u/ml
1.6
2.6
0.74
13
177
(3003338) MCHC [Mass/volume]
3044
30423
1.00
0.01
40.4
17.4
g/l
329.7
332.5
49.52
3007
30154
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
43
423
1.02
0.01
1.3
1.4
nmol/l
0.2
0.3
3.02
27
335
(3002523) Influenza virus A Ag [Presence] in Specimen
45
444
1.01
0.00
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
236
1.02
0.00
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
142
1423
1.00
0.00
1.9
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
159
1.01
0.00
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
115
1.04
0.00
1.1
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
68
680
1.00
0.00
3.2
3.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
129
1.01
0.00
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
51
0.98
0.00
2.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
79
1.01
0.00
1.6
1.2
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
66
0.91
0.00
6.2
7.7
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
71
0.99
0.00
1.1
1.4
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
1.6
—
0
8
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
54
0.93
0.00
1.8
1.6
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
3685.3
—
0
5
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
24.2
—
0
5
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint N14_HYDRONEPHR and mortality.

Females

Parameter HR [95% CI] p-value
N14_HYDRONEPHR 3.907 [3.47, 4.39] < 0.001
Birth year 0.996 [0.99, 1.0] 0.267

During the follow-up period (1.1.1998 — 31.12.2019), 4573 out of 11586 females with N14_HYDRONEPHR died.

Males

Parameter HR [95% CI] p-value
N14_HYDRONEPHR 2.807 [2.45, 3.21] < 0.001
Birth year 0.982 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 5778 out of 12718 males with N14_HYDRONEPHR died.

Mortality risk

Mortality risk for people of age

years, who have N14_HYDRONEPHR.

N-year risk Females Males
1 0.35% 0.429%
5 1.824% 2.82%
10 5.494% 7.038%
15 10.627% 12.816%
20 17.581% 20.234%

Relationships between endpoints

Index endpoint: N14_HYDRONEPHR – Hydronephrosis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data